CA2346074A1 - Apparatus and method to determine blood parameters - Google Patents
Apparatus and method to determine blood parameters Download PDFInfo
- Publication number
- CA2346074A1 CA2346074A1 CA002346074A CA2346074A CA2346074A1 CA 2346074 A1 CA2346074 A1 CA 2346074A1 CA 002346074 A CA002346074 A CA 002346074A CA 2346074 A CA2346074 A CA 2346074A CA 2346074 A1 CA2346074 A1 CA 2346074A1
- Authority
- CA
- Canada
- Prior art keywords
- light
- blood
- conduit
- n815nm
- far
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14535—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring haematocrit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14557—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted to extracorporeal circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
- A61B2560/0228—Operational features of calibration, e.g. protocols for calibrating sensors using calibration standards
- A61B2560/0233—Optical standards
Abstract
The present invention relates to an apparatus for monitoring blood parameter s during cardio-pulmonary bypass surgery or during other procedures which utilize an extracorporeal circuit. The apparatus has a light source (16) whi ch transmits light at a plurality of wavelengths to the conduit. The reflected or transmitted light is received by a near sensor (18) and far sensor (20) from near optical fiber (17) and far optical fiber (19). The near and far sensors generate signals indicative of the intensity of light at a plurality of wavelengths. An arithmetic circuit (25) receives the signals from the near sensor (18) and far sensor (20) and calculates at least one parameter of blood. The apparatus provides real-time results to show immediate changes in the monitored parameters.
Description
APPARATUS AND METHOD TO DETERM)QVE BLOOD PARAMETERS
Field of the Invention s This invention relates to an apparatus and method for determining parameters of blood circulating through an extracorporeal circuit. Most preferably the apparatus determines oxygen saturation, hemoglobin concentration and hematocrit.
i o Background of the Invention Oxyhemoglobin and deoxyhemoglobin differentially absorb red and infrared light. An optical oximeter uses the difference in absorption to measure blood oxygen saturation. The difference in absorption can also be used to measure hematocrit, hemoglobin and other parameters of the blood. One method for 1s measuring hematocrit, hemoglobin and oxygen saturation is by passing red light and infrared light through blood in shorter and longer paths and using the differences in light energy remaining to calculate the desired parameters.
For some medical procedures, an extracorporeal circuit with a pump and an oxygenator is used to temporarily replace the function of the heart and lungs, 2o respectively. To maintain proper physiological conditions, the blood's oxygen saturation and hemoglobin concentration are periodically measured by taking blood samples from the circuit and sending the samples to a clinical laboratory. In the above system, the blood parameters are not continuously monitored. This results in delay for treatment of physiological changes that may be identified by measuring 2s oxygen saturation, hemoglobin and hematocrit.
The delay encountered when blood parameters are measured in a clinical laboratory may be eliminated by directly measuring the parameters of blood as it passes through the extracorporeal circuit. Devices which directly measure the parameters irradiate the blood and measure the reflected or transmitted Light to calculate the blood parameters. However, these devices unnecessarily add to the complexity of the circuit requiring that additional devices, such as cuvettes, be plumbed into the circuit's conduit. Further, because an apparatus must be plumbed s into the circuit, the measurements are taken at a fixed location within the extracorporeal circuit. The operator has no ability to monitor blood parameters at other locations. Also, the splicing of elements into the circuit provides a point for the introduction of pathogens and other contaminants through improper sterilization or during the process of inserting the apparatus into the circuit.
to Other types of detectors suffer from further disadvantages. Some detectors require sensors to physically contact the blood in order to measure the intensity of reflected light. These devices suffer from inaccuracy due to changes over time in the detector under the influence of the blood's physical properties. This alters the measurement of the reflected light detected resulting in an inaccurate measurement 15 of the blood's characteristics. Further, there is a risk of electrical leakage from the electric components that could be detrimental to the patient.
The present invention provides an apparatus and method for measuring blood parameters by attaching sensors to the conduit of an extracorporeal circuit.
Thus, the present invention provides numerous advantages over prior art devices. For 2o example, the present invention eliminates the need for placing sensors in direct contact with the blood and the need for plumbing additional elements into the extracorporeal circuit. Further, the present invention provides the operator with the flexibility to move the clamp to different locations on the extracorporeal circuit's conduit during an operation (e.g. from the venous to the arterial side of the circuit).
2s Also, since the device does not contact the blood, the clamp does not need to be sterilized and there is no risk of electrical leakage.
WO 00/28322 PC'fNS99/25733 Summary of the Invention In one aspect, this invention is an apparatus for monitoring blood parameters during cardio-pulmonary bypass surgery or during other procedures which utilize an extracorporeal circuit. The apparatus is typically used to monitor the percentage of hemoglobin bound with oxygen (oxygen saturation), the total amount of hemoglobin in the blood, and the percent of blood which is comprised of red blood cells (hematocrit), although the apparatus can be adapted to measure other blood parameters. The apparatus (or monitor) provides real-time results to show 1o immediate changes (trending) in the monitored parameters.
In one aspect, the apparatus has a light source which transmits light at a plurality of wavelengths to the conduit. Some of the light source's light is transmitted and some is absorbed by the blood. The reflected or transmitted light is received by a near sensor and a far sensor. The near sensor is connected to receive light a first distance from the light source. The near sensor senses the intensity of light at a plurality of wavelengths. The near sensor generates a signal indicative of the intensity of the sensed light at a plurality of wavelengths. The far sensor is also connected to receive light but at a second distance from the light source not equivalent to that of the first distance. The far sensor also senses the intensity light 2o at a plurality of wavelengths. The far sensor generates a signal indicative of the intensity of light at a plurality of wavelengths. An arithmetic circuit receives the signals from the near sensor and the far sensor and calculates at least one parameter of blood, therefrom. The arithmetic circuit then generates an output signal indicative of the signals.
The light source emits wavelengths between 450nm and 1150nm. The light source can be a tungsten halogen bulb or any other bulb, set of bulbs or set of diodes emitting a sufficient intensity of light at the desired wavelengths.
Field of the Invention s This invention relates to an apparatus and method for determining parameters of blood circulating through an extracorporeal circuit. Most preferably the apparatus determines oxygen saturation, hemoglobin concentration and hematocrit.
i o Background of the Invention Oxyhemoglobin and deoxyhemoglobin differentially absorb red and infrared light. An optical oximeter uses the difference in absorption to measure blood oxygen saturation. The difference in absorption can also be used to measure hematocrit, hemoglobin and other parameters of the blood. One method for 1s measuring hematocrit, hemoglobin and oxygen saturation is by passing red light and infrared light through blood in shorter and longer paths and using the differences in light energy remaining to calculate the desired parameters.
For some medical procedures, an extracorporeal circuit with a pump and an oxygenator is used to temporarily replace the function of the heart and lungs, 2o respectively. To maintain proper physiological conditions, the blood's oxygen saturation and hemoglobin concentration are periodically measured by taking blood samples from the circuit and sending the samples to a clinical laboratory. In the above system, the blood parameters are not continuously monitored. This results in delay for treatment of physiological changes that may be identified by measuring 2s oxygen saturation, hemoglobin and hematocrit.
The delay encountered when blood parameters are measured in a clinical laboratory may be eliminated by directly measuring the parameters of blood as it passes through the extracorporeal circuit. Devices which directly measure the parameters irradiate the blood and measure the reflected or transmitted Light to calculate the blood parameters. However, these devices unnecessarily add to the complexity of the circuit requiring that additional devices, such as cuvettes, be plumbed into the circuit's conduit. Further, because an apparatus must be plumbed s into the circuit, the measurements are taken at a fixed location within the extracorporeal circuit. The operator has no ability to monitor blood parameters at other locations. Also, the splicing of elements into the circuit provides a point for the introduction of pathogens and other contaminants through improper sterilization or during the process of inserting the apparatus into the circuit.
to Other types of detectors suffer from further disadvantages. Some detectors require sensors to physically contact the blood in order to measure the intensity of reflected light. These devices suffer from inaccuracy due to changes over time in the detector under the influence of the blood's physical properties. This alters the measurement of the reflected light detected resulting in an inaccurate measurement 15 of the blood's characteristics. Further, there is a risk of electrical leakage from the electric components that could be detrimental to the patient.
The present invention provides an apparatus and method for measuring blood parameters by attaching sensors to the conduit of an extracorporeal circuit.
Thus, the present invention provides numerous advantages over prior art devices. For 2o example, the present invention eliminates the need for placing sensors in direct contact with the blood and the need for plumbing additional elements into the extracorporeal circuit. Further, the present invention provides the operator with the flexibility to move the clamp to different locations on the extracorporeal circuit's conduit during an operation (e.g. from the venous to the arterial side of the circuit).
2s Also, since the device does not contact the blood, the clamp does not need to be sterilized and there is no risk of electrical leakage.
WO 00/28322 PC'fNS99/25733 Summary of the Invention In one aspect, this invention is an apparatus for monitoring blood parameters during cardio-pulmonary bypass surgery or during other procedures which utilize an extracorporeal circuit. The apparatus is typically used to monitor the percentage of hemoglobin bound with oxygen (oxygen saturation), the total amount of hemoglobin in the blood, and the percent of blood which is comprised of red blood cells (hematocrit), although the apparatus can be adapted to measure other blood parameters. The apparatus (or monitor) provides real-time results to show 1o immediate changes (trending) in the monitored parameters.
In one aspect, the apparatus has a light source which transmits light at a plurality of wavelengths to the conduit. Some of the light source's light is transmitted and some is absorbed by the blood. The reflected or transmitted light is received by a near sensor and a far sensor. The near sensor is connected to receive light a first distance from the light source. The near sensor senses the intensity of light at a plurality of wavelengths. The near sensor generates a signal indicative of the intensity of the sensed light at a plurality of wavelengths. The far sensor is also connected to receive light but at a second distance from the light source not equivalent to that of the first distance. The far sensor also senses the intensity light 2o at a plurality of wavelengths. The far sensor generates a signal indicative of the intensity of light at a plurality of wavelengths. An arithmetic circuit receives the signals from the near sensor and the far sensor and calculates at least one parameter of blood, therefrom. The arithmetic circuit then generates an output signal indicative of the signals.
The light source emits wavelengths between 450nm and 1150nm. The light source can be a tungsten halogen bulb or any other bulb, set of bulbs or set of diodes emitting a sufficient intensity of light at the desired wavelengths.
The near sensor is preferably a first charge coupled device and the far sensor is preferably a second charge coupled device of a single two-channel spectrometer.
Alternatively, the near sensor could be a first spectrometer and the far sensor could be a second spectrometer.
s The arithmetic circuit could derive the blood oxygen saturation from the ratios of reflected light at wavelengths between 660nm and 815nm in accordance with the formula: oxygen saturation = A(n680nm/n815nm)3 +
B(n680nm/n815nm)2 + C(n680nm/n815nm) + D(n680nm/n815nm)~' +
E(n680nm/n815nm)-2 + F(n710nm/n740nm)3 + G(n710nm/n740nm)2 +
1o H(n710nm/n740nm) + I(n710nm/n740nm)-' + J(n710nm/n740nm)-2 +
L(n760nm/n815nm)3 +M(n760nm/n815nm)2 + N(n760nrn/n815nm) +
O(n760nm/n815nrn)-' + P(n760nm/n815nm) -'' + T(f680nm/f$ l5nm)3 +U(f680nm/f8l5nm)2 + V(f680nm/f815nm) + W(f680nrn1f815nm)-' +
X(f680nm/f815nm) -2 + Y(f710nm/f740nm)3 + Z(f710nm/f740nm)Z +
15 AA(f710nm/f740nm) + BB(f710nm/f740nm)-' + CC(f710nm/f740nm)-Z +
DD(f760nm/f815nm)3 + EE(f760nm/f815nm)' + FF(f760nm/f815nm) +GG{f760nm/f815nm)-' + HH(f760nm/f815nm)-2 + II(n815nm/f810nm)3 +
JJ(n815nm/f810nm)2 + KK(n815nm/f810nm) + LL wherein A to LL are constants, n designates the reflectance detected by the near sensor, and f designates the 2o reflectance detected by the far sensor. Although, any formula from which blood oxygen saturation is derived using a plurality of wavelengths measured at neax and far sensors would be sufficient.
The arithmetic circuit could derive one of hemoglobin concentration and hematocrit from the ratios of reflected light at a plurality of wavelengths between 25 760nm and 999nm in accordance with the formula: hemoglobin and hematocrit =
A(n815nm/f810nm)3 + B(n815nm/f810nm)2 + C(n815nm/f810nm) +
D(n815nm/f810nm)-' + E(n815nm/f810nm)-2 + F(n850nm/f825nm)3 +
G(n850nm/n825nm)2 + H(n850nm/f825nm) +I(n850nm/f825nm)-' +
WO OOI2$322 PCT/US99/Z5733 J(n850nm/f825nm)-2 + O(n880nm/f827nm)3 + P(n880nm/f827nm)2 +
Q(n880nm/f827nm) + R(n880nm/f827nm)-' + S(n880nm/f827nm)-2 +
U(n900nm/f830nm)3 + V(n900nm/f830nm)2 + W(n900nm/f830nm) +
X(n900nm/f830nm) -1 +Y(n900nm/F830nm)-2 + Z(n999nm/f935nm)3 +
s AA(n999nm/f935nm)2 + BB(n999nm/f935nm) + CC(n999nm/f935nm)-' +
DD(n999nm/f935nm)-2 + EE(n760nm/n815nm)3 + FF(n760nm/n815nm)2 +
GG(n760nm/n815nm) + HH when blood hemoglobin concentration is less than 9 or hematocrit is less than 25; and hemoglobin and hematocrit =
A(n802nmN'/f802nmD')3 + B(n802nmN'/f802nmD')2 + C(n802nmN'/f802nmD') +
D(n802nmN'/f802nmD')-' + E(n802nmN'/f802nmD')-2 + I(n803nmN2/f803nmDZ)s +
J(n803nmN2f803nmDZ)z + K(n803nmN2/f803nmD2) + L(n803nmN2/f803nmD2)-' +
M(n803nmN2/f803nmDa)-z + O(n805nmN3/f802nmD2)3 + p{n805nmN3/f802nmDS)a + Q(n805nmN3/f802nmD3) + R(n805nmN3/f802nmD3)-' + S(n8O5nmN3/f8O2nmDS)-2 + U(n8lOnmN4/f8O3nmDa)s + V{n8lOnmN4/f$O3nmDa)z + W(n8lOnmN4/f8O3nmDa) + X(n810nmN4/f803nmD4) -' + Y(n810nmN4/f803nmDa)-2 + FF{n760nm/n815nm)3 + GG(n760nm/n815nm)2 + HH(n760nm/n815nm) + II when blood hemoglobin concentration is greater than or equal to 9 or hematocrit is greater than or equal to wherein, A to LL are constants, n designates the reflectance detected by the near sensor, and f designates the reflectance detected by the far sensor. Although, any 2o formula from which hemoglobin and/or hematocrit are derived using a plurality of wavelengths measured at near and far sensors would be sufficient..
The apparatus preferably uses a source optical fiber to transmit light from the light source to the conduit. The source optical fiber having a first end connected to the light source and a second terminal end connected adjacent the conduit.
25 Preferably, the near sensor receives light from a near optical fiber. The near optical fiber having a first end connected to the near sensor and a second terminal end connected adjacent the conduit. Preferably, the far sensor receives light from a far optical fiber. The far optical fiber having a first end connected to the far sensor and a second terminal end connected adjacent the conduit.
The apparatus preferably includes a clamp. The clamp secures a terminal end of the source optical fiber, a terminal end of the near optical fiber and a s terminal end of the far optical fiber such that the source fiber, the near optical fiber and the far optical fiber are in optical communication with the extracorporeal circuit's conduit. The clamp preferably secures the terminal ends of the source optical fiber, the near optical fiber and the far optical fiber such that the terminal ends of the optical fibers are biased against the conduit. The clamp preferably to secures the terminal ends such that the ends are oriented substantially perpendicular to the fluid flow through the conduit.
The terminal ends of the near and far optical fibers are differentially spaced from the terminal end of the source optical fiber. The terminal end of the near optical fiber is preferably positioned about 0.8mm from the terminal end of the 1s source optical fiber. The terminal end of the far optical fiber is preferably positioned about l.2mm from the terminal end of source optical fiber. The terminal ends of the near optical fiber, the far optical fiber and the source optical fiber can positioned co-axially along the flow path of blood in the conduit.
In another aspect, the invention is a method for measuring a blood 2o parameter. The method includes passing through a conduit in an extracorporeal circuit with a blood monitor having a light source, a near sensor and a far sensor.
The light source emits a plurality of wavelengths through the conduit into the blood.
The light reflected by the blood is directed to the near sensor. The light reflected by the blood is also directed to the far sensor. The quantity of reflected light 2s received by the blood at the near sensor and the far sensor is measured at a plurality of wavelengths. The measured quantity of reflected light at the near sensor and the far sensor is used to calculate the desired blood parameter using a plurality of wavelengths.
In another aspect, the invention is a method for measuring a blood parameter using a clamp to mount optical fibers to the conduit. The method includes providing a blood monitor having a near sensor, a far sensor and a light source which are connected by optical fibers to a clamp. The clamp is mounted on the s conduit in a manner such that terminal ends of the optical fibers are held against the outer surface of the conduit. Light is emitted at a plurality of wavelengths through the conduit into the blood. The light reflected by the blood at a plurality of wavelengths is received by the sensors. The light received by the near and the far sensors is quantitated at a plurality of wavelengths. The values for blood to parameters are then calculated from the quantity of reflected light.
In another aspect, the invention is a clamp for positioning optical fibers against a conduit to measure reflected light. The clamp includes a body defining a cavity shaped to accept the conduit and a mating piece movably attached to the body. The mating piece is shaped so as to cooperate with the body to securedly 1s hold the conduit. The mating piece is preferably hingedly attached to the body. At least two optical fibers mounted in the body, wherein terminal ends of the optical fibers extend into the cavity. The body and mating piece cooperate to hold the conduit such that in a closed position the conduit is compressionally biased against the terminal ends of the optical fibers. The clamp can include a lock for 2o maintaining the mating piece in the closed position. The clamp can have the terminal ends of the optical fibers positioned co-axially along the flow path of blood in the conduit. The clamp can secure three optical fibers, a first fiber, a second fiber secured about 0.8mm from the first fiber and a third fiber secured about l.2mm from the light source.
25 In another aspect, the invention is a clamp for positioning optical fibers against a conduit for measuring blood parameters using transmitted light. The clamp includes a body defining a cavity shaped to accept conduit. At least one optical fiber is secured in the body with the terminal end of the optical fiber extending into the cavity. A mating piece movably attached to the body. The cavity and the mating piece shaped so as to cooperate in securing the conduit when in a closed position. At least two optical fibers are mounted in the mating piece such that terminal ends of the fibers extend into the are positioned opposite the cavity so as to receive light transmitted through the blood from an optical fiber in the cavity of the body. The terminal ends of the optical fibers are positioned such that they are compressionally biased against the conduit when the conduit is held in the clamp.
In another aspect, the invention is a method for calibrating a blood monitor.
The monitor to be calibrated having a light source and a spectrometer with at least one charge coupled device array which measures blood parameters in an extracorporeal circuit. The method including masking pixels of the charge coupled device array. A dark reference is measured from the masked pixels of the charge coupled device array. A light reference is measured using the light from the light source reflected by a diffuse reflective material. The values for reflected light are normalized using the measured light reference and the measured dark reference.
In another aspect, the invention is a method of regulating use of a medical monitor. The method for regulating uses includes providing a key encoded with data indicative of a pre-selected number of uses and providing firmware in the 2o monitor which recognizes the data encoded key. The firmware and the data encoded key are electrically connected wherein the data encoded key activates the monitor for the pre-selected number of uses. A use can include continuously running of the monitor for eight hours, removing of the clamp for a specified period of time or any other activity indicative of a complete cycle of use.
Alternatively, the method of regulating use of the medical monitor includes providing circuitry to disable the monitor and providing firmware in the monitor that can be programmed for a pre-selected number of uses. The firmware is coupled to the disabling circuitry in a manner so as to disable the monitor after the pre-selected number of uses.
Brief Description of the Drawings s Fig. 1 is a perspective view of a preferred embodiment of the blood monitor;
Fig. 2a is a perspective view of an embodiment of the clamp in the open position;
Fig. 2b is a perspective view of an embodiment of the clamp in the closed position;
1o Fig. 2c is a perspective view of an embodiment of the adapter insert;
Fig. 3a is an enlarged cross-sectional view from the top of an embodiment of the clamp;
Fig. 3b is an enlarged cross-sectional view from the front of an embodiment of the clamp;
~s Fig 3c is a detailed view of the terminal ends of the optical fibers;
Fig. 4 is a block diagram of an embodiment of the blood monitor's operation;
Fig. 5 is a perspective view of an embodiment of the calibration post; and Fig. 6 is a block diagram showing the method of operation of the key 2o reader.
Detailed Description of the Invention The present invention is a monitor or apparatus for monitoring blood parameters and utilizes a polychromatic light beam which is directed into blood.
The extent of absorption, refraction, scattering and reflection of the light is 2s determined by the chemistry and physical properties of the blood. Incident light is absorbed, refracted, scattered and reflected by the blood. At each wavelength, a fraction of incident light is either absorbed, scattered or reflected. This absorbed, scattered or reflected light can be detected by sensors in order to measure and monitor oxygen saturation, hematocrit, hemoglobin, oxyhemoglobin, deoxyhemoglobin, carboxy-hemoglobin, methoxy-hemoglobin, and bilirubin and further can determine cell counts for erythrocytes and platelets.
The diagram of Fig. 1 shows an embodiment of the instant invention used s for measuring blood parameters, in particular for measuring .oxygen saturation, hematocrit and hemoglobin. The diagram shows clamp 30 secured to conduit 10 of an extracorporeal circuit. Clamp 30 securely holds the ends of optical fibers contained in fiber optic cable 14. Conduit 10 can be any optically clear element of the extracorporeal circuit through which blood within the circuit passes, such as a 1o cuvette, but is preferably optically clear tubing or more preferably clear polyvinylchloride (PVC) tubing. An optical fiber directs light to the blood from a light source located in housing 11. A plurality of optical fibers receive light reflected from the blood and direct light to one or more spectrometers located in housing 11. Clamp 30 secures the ends of the optical fibers to the conduit 10 such that the blood flows through conduit 10 substantially perpendicular to the optical fibers. In a preferred embodiment, the housing includes a numeric display 21 displaying the values for oxygen saturation, hematocrit and hemoglobin concentration. In a more preferred embodiment, numeric display 21 is a monitor having five seven-segment LED's displaying the parameters. The housing can also 2o contain an alphanumeric display 22 to communicate information to the perfusionist regarding the status of the monitor and the patient. In a preferred embodiment, alphanumeric display 22 is a vacuum fluorescent display {VFD). Further, housing 18 preferably includes the controls for the operation and adjustment of the monitor and selection of the blood parameter to be displayed.
Figs. 2a, 2b and 2c show a preferred embodiment of conduit clamp 30.
Conduit clamp 30 is composed of a body 32 and a mating piece 34. Body 32 defines a cavity 36 shaped to secure conduit 10 of an extracorporeal circuit.
Mating piece 34 defines a cavity 38 and is attachable to body 32 such that the mating piece 34 can be in an open position, shown in Fig. 2a, or a closed position, shown in Fig. 2b. In a preferred embodiment mating piece 34 is hingedly attached to body 32 and is provided with a locking apparatus 40 to secure body 32 and mating piece s 34 in the closed position. Most preferably, locking apparatus 40 is a stainless steel short spring plunger and detent so clamp 30 is not accidentally removed from conduit 10. When in the closed position body cavity 36 and mating piece cavity cooperate to secure conduit 10.
In an alternative embodiment cavity 38 is provided with an adapter 42 allowing smaller diameter or alternatively shaped conduit to be secured in clamp 30.
The design of clamp 30 provides increased ambient light isolation and easy placement anywhere on the extracorporeal circuit. For example, the operator can place the clamp on conduit either upstream or downstream of the oxygenator allowing measurement of the parameters of venous or arterial blood, respectively.
1s In another alternative embodiment, not shown, a near optical fiber and a far optical fiber are mounted on a mating piece on the opposite side of conduit 10 from the light source such that the optical fibers are differentially spaced from the light source and detect light transmitted through the blood flowing through the conduit as opposed to reflected light. Most preferably, the mating piece is configured such 2o that, in the closed position, the ends of the optical fibers are biased against the conduit of the circuit. In order for the sensors to be able to pick up sufficient transmitted light so that the desired parameters can be measured, the conduit should be of a diameter small enough such that sufficient light from the light source is transmitted through the blood and received by the near and far sensors that are 2s differentially spaced from the light source. Additionally or alternatively, the light source's intensity could be increased such that light from Iight source is capable of penetrating the blood flowing through standard sized extracorporeal circuit conduit to reach the sensors mounted on the mating piece opposite the light source.
Figs. 3a, 3b and 3c show detailed cross sectional views of an embodiment of clamp 30. In this embodiment, a ferrule 50 securedly holds the terminal ends of three optical fibers. An optical fiber 15 is in optical communication with the light s source 16. A near optical fiber 17 is in optical communication with near sensor 18.
A far optical fiber 19 is in optical communication with far sensor 20.
Preferably, the ends of the optical fibers are positioned substantially coplanar with the end of ferrule 50. Further, the ends of the optical fibers are preferably polished such that light transmitted or received is not distorted by irregularities in the ends of the optical fibers. Ferrule 50 is securedly mounted in body 32 such that optical fiber 15, near optical fiber 17 and far optical fiber 19 are in optical communication with conduit 10. Clamp 30 positions ferrule 50 relative to conduit IO such that light transmitted from light source 16 passes through optical fiber 15 and conduit 10.
The path of light emitted from optical fiber 15 is preferably substantially 15 perpendicular to the flow of blood within conduit 10. The light reflected by the blood passes back through conduit 10 and is transmitted by near optical fiber 17 and far optical fiber 19 to near sensor 18 and far sensor 20, respectively. In a more preferred embodiment, the end of ferrule 50 extends through body 32 beyond the inner wall of cavity 36 such that conduit 10 held by clamp 30 is biased against the 2o end of the ferrule 50 as shown in Fig. 3a. This biased configuration assures that there is no space between conduit 10 and ferrule 50 and therefore, no disruption of the light path. In an alternative embodiment, not shown, ferrule 50 and body 32 are integrated into a single element securing optical fiber 15, near optical fiber 17 and far optical fiber 19.
2s Near optical fiber 17 and far optical fiber 19 receive light at different distances from optical fiber 15. The near and far optical fibers are positioned from between about 0.6mm to about 3.Omm from optical fiber 15 such that a sufficient amount of light is received by far optical fiber 19 to produce the data necessary to calculate the desired parameters. In a preferred embodiment, near optical fiber 17 receives light at a distance of about 0.8mm from optical fiber 15 and far optical fiber 19 receives light at a distance of about l.2mm from optical fiber 15. In a most preferred embodiment, the optical fibers are positioned axially along the s blood's flow path wherein, near optical fiber 17 is located 0.8mm upstream from optical fiber 15 and far optical fiber 19 is located l.2mm downstream from optical fiber 15.
The block diagram of Fig. 4 shows the mechanism of the monitor's operation. Light source 16 directs light into blood flowing through conduit 10.
1o The light is absorbed, refracted, scattered and reflected by the blood.
Reflected light is received by near optical fiber 17 and far optical fiber 19 and is transmitted to near sensor 18 and far sensor 20, respectively. The near and far sensors quantitate the light received at a plurality of wavelengths. The light's intensity is normalized at each of the plurality of wavelengths by the arithmetic circuit 25. The 15 arithmetic circuit 25 then uses the normalized intensities to calculate the values for the blood parameters and produce an output 24. In another embodiment, an additional optical fiber guides light from the light source to a silicone photodiode 27. Photodiode 27 provides an extra measure of safety in case of burnout of the light source as well as providing trending of light source's intensity.
2o In one embodiment, light source 16 directs a plurality of wavelengths between about 300nm to about 10,000nm and more preferably between about 405nm and about 1100nm into conduit 10. Most preferably, the light source 16 is a tungsten halogen bulb, although any bulb emitting a sufficient intensity of light over the desired spectrum could be used. In another embodiment, a plurality of light 2s sources each emitting discrete spectra, such as light emitting diodes (LEDs), are used to emit the desired wavelengths of light. The plurality of light sources are either combined or sequentially emitted and directed to a single point along the extracorporeal circuit using optical fiber 15.
In a preferred embodiment, near sensor 18 is a first channel of a two-channel spectrometer receiving light from near optical fiber 17 and far sensor 20 is a second channel of the spectrometer receiving light from far optical fiber 19. The first and second channels are separate optical blocks electronically connected as a single two-channel spectrometer. Alternatively, near sensor 18 could comprise a first spectrometer receiving light from near optical fiber 17 and the far sensor could comprise a second spectrometer receiving light from far optical fiber 19. In still another embodiment, the near and far sensors could share a single spectrometer having a single channel switching between and separately quantitating light received 1o from near optical fiber 17 and far optical fiber 19. Regardless of configuration, the sensors quantitate the amount of light received from near optical fiber 17 and far optical fiber 19 at a plurality of wavelengths and transmit the data to the arithmetic circuit 25. The arithmetic circuit 25 then calculates the values for oxygen saturation, hematocrit and hemoglobin concentration using the input from near is sensor 18 and far sensor 20.
Before using the monitor, a two-point calibration is performed. The two-point calibration establishes a light reference and a dark reference. The dark reference measures the electrical stability of the optical system. The dark reference is determined by measuring the output from masked pixels of the spectrometer's 2o CCD (charge coupled device) array. The light reference measures the intensity of the light source. The light reference is the intensity of reflected light received by the near and far optical fibers from a diffuse reflective material. The light reference is taken without tubing or other obstruction in the light path. The values for the light reference and a first dark reference are recorded and stored for data 25 normalization.
To perform a two-point calibration, clamp 30 is preferably mounted on a calibration post 60, shown in Fig. 5. Post 60 is shaped such that the post can be seeuredly held by clamp 30. Post 60 defines a cavity 64 in which diffuse reflective material 62 is located. The cavity provides an unobstructed path for light emitted from source fiber 15 and reflected from diffuse reflective material 62 to be received by near optical fiber 17 and far optical fiber 19. Diffuse reflective material 62 is preferably a sputtered gold mirror or a material with similar reflective properties 5 such as that commercially available as Spectralon~ from Labsphere , Inc.
located in North Sutton, New Hampshire. In a preferred embodiment, one or more alignment pins 65 are provided on calibration post 60 such that the alignment pins cooperate with cavities on clamp 30 to secure diffuse reflective material 62 in the proper orientation for calibration. When clamp 30 is mounted on post 60, optical fiber 15 io is oriented above the cavity such that light is emitted in a direction substantially perpendicular to the plane of the reflective material 62. In an alternative embodiment, mating piece cavity 38 is positioned opposite ferrule 50 and contains a calibrated diffuse reflective material for measuring the light reference. In a most preferred embodiment, during a two-point calibration, the monitor senses when 15 either the angle of incidence or the intensity of the light reference are incorrect and displays an error message on the alphanumeric display.
In operation, light source 16 is turned on and clamp 30 is placed on post 60.
After emissions from light source 16 have stabilized the monitor measures light 2o received by near optical fiber 17 and far optical fiber 19 and stores the measurement as the light reference for near sensor 16 and far sensor 18, respectively. The CCD
array's masked pixels for both near sensor 16 and far sensor 18 are also measured and stored during calibration to establish a dark reference. After the two-point calibration is performed the clamp is placed on the conduit of the extracorporeal circuit.
The data from the two-point calibration is used to normalize data used to calculate the blood parameters. The data is normalized pursuant to the formula:
~Inormalized~6W16-ldark~t=t~Uhigh~6-Idark~t=0 ~EQuation 1~
wherein, "I" is the intensity of light, t=0 is the time of calibration, t=t is the time at which intensity is measured, and 6 is a wavelength at which the reflectance is measured. A first dark reference, Idarx, is obtained at t=0. The light reference, hight6~ is also obtained at t=0 after stabilization of the intensity of the light source's s emission spectra. The light and first dark references are used in Equation 1 to normalize the data and remain constant until another two-point calibration is initiated. In finding the normalized intensity, Ino,."~,~,;~ed6, the arithmetic circuit 25 receives the input of the reflected intensity, I6, at a plurality of wavelengths. The reflected intensity is the intensity of light received by near optical fiber 17 and far optical fiber 19 at time t=t after transmission of light through the conduit, reflectance of light by the blood and transmission back through the conduit to the sensors. A second dark reference, Nark, is also taken at time t=t by again sampling the masked pixels of the CCD array. The second dark reference measures the electrical stability of the optical system at the time t=t and may vary unlike the first 1s dark reference. The normalized intensity, Ino~,;~ea6, resulting from Equation 1 is used by the arithmetic circuit 25 to calculate the desired blood parameters.
The arithmetic circuit 25 preferably uses a third order polynomial equation to calculate the desired blood parameters. The variables input into the equation to calculate hematocrit, hemoglobin and oxygen saturation are ratios of the normalized 2o intensities of a plurality of wavelengths in a range between 405nm and 999nm received by the near and far sensors. The individual third order polynomial equations used for calculating oxygen saturation, hematocrit and total hemoglobin are established using non-linear mufti-variable regression analysis. The regression analysis can be accomplished using a standard statistical program, such as that 2s commercially available as Statistics from StatSoft'~, Inc. located in Tulsa, Oklahoma. The data for regression analysis is obtained by measuring the reflection of blood with defined parameters at the selected wavelengths with an acceptable laboratory instrument or other suitably accurate means. To assure accurate measurements a total of at least four wavelengths are input into the equation.
At least one of the wavelengths used in the equation should be selected from the range of isobestic wavelengths for hemoglobin. The isobestic wavelengths for hemoglobin fall in the range between 802nm and 815nm. Preferably the wavelengths are s selected from the group consisting of 680nm, 710nm, 740nm, 760nm, 802nm, 803nm, 805nm, 810nm, 815nm, 825nm, 827nm, 830nm, 850nm, 880nm, 900nm, 935nm, and 999nm. The wavelengths input into the arithmetic apparatus are selected on the basis of spectral absorption curves of the blood parameters.
In a most preferred embodiment, the third order polynomial for measuring the oxygen saturation (Sat) is the formula:
Sat = A(n680nm/n815nm)3 + B(n680nm/n815nm)2 + C(n680nm/n815nm) + D(n680nm/n815nm)-' + E(n680nm/n815nm)~' + F(n710nm/n740nm)3 +
G(n710nm/n740nm)2 + H(n710nm/n740nm) + I{n710nm/n740nm)-' +
J(n710nm/n740nm) ' + L(n760nm/n815nm)3 +M(n760nm/n815nm)2 +
1s N(n760nm/n815nm) + O(n760nm/n815nm)-1 + P(n760nm/n8l5nm) -2 +
T(f680nm/f815nm)3 +U(f680nm/f815nm)2 + V(f680nm/f815nm) +
W(f680nm/f815nm)-' + X(f680nm/f815nm) -2 + Y(f710nm/f740nm)3 +
Z(f710nm/f740nm)2 + AA(f710nm/f740nm) + BB(f710nm/f740nm)-1 +
CC(f7l0nm/f740nm)-2 + DD(f760nm/f815nm)3 + EE(f760nm/f815nm)2 +
2o FF(f760nm/f815nm) +GG(f760nm/f815nm)-' + HH(f760nm/f815nm)-2 +
II(n815nm/f810nm)3 + JJ(n815nm/f810nm)2 + KK(n815nm/f810nm) + LL
wherein A to LL are constants established by non-linear mufti-variable regression analysis and "n" designates the normalized intensity of light received by the near sensor at the respective wavelength and "f" designates the normalized intensity of 2s light received by the far sensor at the respective wavelength.
In a most preferred embodiment, the arithmetic means bifurcates the calculation of hemoglobin and hematocrit between two formulas dependent on the concentration of total hemoglobin (Hgb) and the hematocrit (Hct) in the sample being monitored. The arithmetic means bifurcates the calculation because the curves generated by the third order polynomial equations are non-monotonic curves over certain ranges of total hemoglobin and hematocrit. Therefore, two separate s equations were developed wherein the curves are monotonic over alternative ranges.
The first equation is monotonic over a low range corresponding to a Hct of less than twenty five or alternatively, a Hgb of less than nine. The second equation is monotonic over a high range corresponding to a Hct of greater than or equal to twenty five or alternatively, a Hgb of greater than or equal to nine. If the value falls into the low range the arithmetic circuit 25, most preferably, uses the formula:
Hgb or Hct = A(n815nm/f810nm)3 + B(n815nm/f810nm)2 +
C(n815nm/f810nm) + D(n815nm/f810nm)-' + E(n815nrn/f810nm)-2 +
F(n850nm/f825nm)~ + G(n850nm/n825nm)2 + H(n850nm/f825nm) +I(n850nm/f825nm)-' + J(n850nm/f825nm)-2 + O(n880nm/f827nm)3 +
~s P(n880nm/f827nm)2 + Q(n880nm/f827nm) + R(n880nm/f827nm)-~ +
S(n880nm/f827nm)-2 + U(n900nm/f830nm)3 + V(n900nm/f830nm)2 +
W(n900nm/f830nm) + X(n900nm/f830nm) -' +Y(n900nm/F830nm)-Z +
Z(n999nm/f935nm)3 + AA(n999nm/f935nm)2 + BB(n999nm/f935nm) +
CC(n999nm/f935nm)-' + DD(n999nm/f935nm)-' + EE(n760nm/n815nm)3 +
2o FF(n760nm/n815nm)2 + GG(n760nm/n815nm) + HH
If the values fall into the high range, the arithmetic circuit 25 most preferably uses the formula:
Hgb or Hct = A(n802nmN'/f802nmD')3 + B(n802nmN'/f802nmD')2 +
C(n802nmN'/f802nmD') + D(n802nmN'/f802nmD')-' +
2s E(n802nmN'/f802nmD')-2 + I(n803nmN2/f803nmDa)s + J(n803nmN2f803nmDa)a + K(n803nmN2/f803nmD2) + L(n803nmN2/f803nmD2)-' +
M(n803nmN2/f803nmDa)-2 + O(n805nmN3/f802nm"2)3 +
P(n805nmN3/f802nmD3)z + Q(n805nmN3/f802nmD3) +
R(nBOSnmN3/f8O2nmD3)~' + S(nBOSnmN3/f8O2nmp3)-2 +
U(n8lOnmN4/f8O3nmp4)3 + V(n8lOnmN4/f8O3nmD4)a +
W(n8lOnmN4/f8O3nmD4) + X(n8lOnmN4/f8O3nmDa) -i +
Y(n810nmN4/f803nmDa)-2 + FF(n760nm/n815nm)3 + GG(n760nm/n815nm)2 + HH(n760nm/n815nm) + II
wherein A to II, N 1 to N4, and D 1 to D4 are constants established independently for Hct and Hgb by non-linear mufti-variable regression analysis and "n"
designates the normalized intensity of light received by the near sensor at the respective wavelength and "f" designates the normalized intensity of light received 1o by the far sensor at the respective wavelength.
Arithmetic circuit 25 provides the results of these calculations as output 24.
Preferably, the values generated by the arithmetic circuit 25 are displayed on numeric display 20. In a most preferred embodiment, the user selects alternatively whether Hct or Hgb will be calculated and displayed.
A one-point calibration can also be performed on the monitor in order to adjust the output to equal that of a laboratory instrument and thus, increase the accuracy of the displayed measurement. To perform a one-point calibration the user draws a blood sample from the extracorporeal circuit while substantially simultaneously storing the values for the parameters being measured by the monitor.
2o The user then measures the parameters on a separate apparatus and inputs the values into the monitor. The separate apparatus is preferably a laboratory instrument or other suitably accurate apparatus. The monitor's software adjusts the parameter values by adding or subtracting an offset value, based on the difference between apparatus and monitor values.
The monitor can be further provided with an apparatus for regulating the number of uses. Preferably, the apparatus comprises a data encoded key, a receptacle on the monitor for receiving and reading the key, and firmware recognizing the encoded data. In operation, the electronic key encoded with erasable data recognized by the firmware as a number of uses. The key is inserted into the receptacle and the firmware reads the data encoded on the key. The firmware then prompts the user to load all or a lesser number of uses. The total number of uses loaded by the user is subtracted from the key and loaded into the monitor. Each time the monitor is used the arithmetic circuit reduces the number of 5 uses left on the monitor by one. A use is defined by the manufacturer. In a most preferred embodiment, the use comprises continuous operation for eight hours or removal from the conduit for a set period of time. A suitable method for such regulation is shown diagrammatically in Fig. 6.
Alternatively, the near sensor could be a first spectrometer and the far sensor could be a second spectrometer.
s The arithmetic circuit could derive the blood oxygen saturation from the ratios of reflected light at wavelengths between 660nm and 815nm in accordance with the formula: oxygen saturation = A(n680nm/n815nm)3 +
B(n680nm/n815nm)2 + C(n680nm/n815nm) + D(n680nm/n815nm)~' +
E(n680nm/n815nm)-2 + F(n710nm/n740nm)3 + G(n710nm/n740nm)2 +
1o H(n710nm/n740nm) + I(n710nm/n740nm)-' + J(n710nm/n740nm)-2 +
L(n760nm/n815nm)3 +M(n760nm/n815nm)2 + N(n760nrn/n815nm) +
O(n760nm/n815nrn)-' + P(n760nm/n815nm) -'' + T(f680nm/f$ l5nm)3 +U(f680nm/f8l5nm)2 + V(f680nm/f815nm) + W(f680nrn1f815nm)-' +
X(f680nm/f815nm) -2 + Y(f710nm/f740nm)3 + Z(f710nm/f740nm)Z +
15 AA(f710nm/f740nm) + BB(f710nm/f740nm)-' + CC(f710nm/f740nm)-Z +
DD(f760nm/f815nm)3 + EE(f760nm/f815nm)' + FF(f760nm/f815nm) +GG{f760nm/f815nm)-' + HH(f760nm/f815nm)-2 + II(n815nm/f810nm)3 +
JJ(n815nm/f810nm)2 + KK(n815nm/f810nm) + LL wherein A to LL are constants, n designates the reflectance detected by the near sensor, and f designates the 2o reflectance detected by the far sensor. Although, any formula from which blood oxygen saturation is derived using a plurality of wavelengths measured at neax and far sensors would be sufficient.
The arithmetic circuit could derive one of hemoglobin concentration and hematocrit from the ratios of reflected light at a plurality of wavelengths between 25 760nm and 999nm in accordance with the formula: hemoglobin and hematocrit =
A(n815nm/f810nm)3 + B(n815nm/f810nm)2 + C(n815nm/f810nm) +
D(n815nm/f810nm)-' + E(n815nm/f810nm)-2 + F(n850nm/f825nm)3 +
G(n850nm/n825nm)2 + H(n850nm/f825nm) +I(n850nm/f825nm)-' +
WO OOI2$322 PCT/US99/Z5733 J(n850nm/f825nm)-2 + O(n880nm/f827nm)3 + P(n880nm/f827nm)2 +
Q(n880nm/f827nm) + R(n880nm/f827nm)-' + S(n880nm/f827nm)-2 +
U(n900nm/f830nm)3 + V(n900nm/f830nm)2 + W(n900nm/f830nm) +
X(n900nm/f830nm) -1 +Y(n900nm/F830nm)-2 + Z(n999nm/f935nm)3 +
s AA(n999nm/f935nm)2 + BB(n999nm/f935nm) + CC(n999nm/f935nm)-' +
DD(n999nm/f935nm)-2 + EE(n760nm/n815nm)3 + FF(n760nm/n815nm)2 +
GG(n760nm/n815nm) + HH when blood hemoglobin concentration is less than 9 or hematocrit is less than 25; and hemoglobin and hematocrit =
A(n802nmN'/f802nmD')3 + B(n802nmN'/f802nmD')2 + C(n802nmN'/f802nmD') +
D(n802nmN'/f802nmD')-' + E(n802nmN'/f802nmD')-2 + I(n803nmN2/f803nmDZ)s +
J(n803nmN2f803nmDZ)z + K(n803nmN2/f803nmD2) + L(n803nmN2/f803nmD2)-' +
M(n803nmN2/f803nmDa)-z + O(n805nmN3/f802nmD2)3 + p{n805nmN3/f802nmDS)a + Q(n805nmN3/f802nmD3) + R(n805nmN3/f802nmD3)-' + S(n8O5nmN3/f8O2nmDS)-2 + U(n8lOnmN4/f8O3nmDa)s + V{n8lOnmN4/f$O3nmDa)z + W(n8lOnmN4/f8O3nmDa) + X(n810nmN4/f803nmD4) -' + Y(n810nmN4/f803nmDa)-2 + FF{n760nm/n815nm)3 + GG(n760nm/n815nm)2 + HH(n760nm/n815nm) + II when blood hemoglobin concentration is greater than or equal to 9 or hematocrit is greater than or equal to wherein, A to LL are constants, n designates the reflectance detected by the near sensor, and f designates the reflectance detected by the far sensor. Although, any 2o formula from which hemoglobin and/or hematocrit are derived using a plurality of wavelengths measured at near and far sensors would be sufficient..
The apparatus preferably uses a source optical fiber to transmit light from the light source to the conduit. The source optical fiber having a first end connected to the light source and a second terminal end connected adjacent the conduit.
25 Preferably, the near sensor receives light from a near optical fiber. The near optical fiber having a first end connected to the near sensor and a second terminal end connected adjacent the conduit. Preferably, the far sensor receives light from a far optical fiber. The far optical fiber having a first end connected to the far sensor and a second terminal end connected adjacent the conduit.
The apparatus preferably includes a clamp. The clamp secures a terminal end of the source optical fiber, a terminal end of the near optical fiber and a s terminal end of the far optical fiber such that the source fiber, the near optical fiber and the far optical fiber are in optical communication with the extracorporeal circuit's conduit. The clamp preferably secures the terminal ends of the source optical fiber, the near optical fiber and the far optical fiber such that the terminal ends of the optical fibers are biased against the conduit. The clamp preferably to secures the terminal ends such that the ends are oriented substantially perpendicular to the fluid flow through the conduit.
The terminal ends of the near and far optical fibers are differentially spaced from the terminal end of the source optical fiber. The terminal end of the near optical fiber is preferably positioned about 0.8mm from the terminal end of the 1s source optical fiber. The terminal end of the far optical fiber is preferably positioned about l.2mm from the terminal end of source optical fiber. The terminal ends of the near optical fiber, the far optical fiber and the source optical fiber can positioned co-axially along the flow path of blood in the conduit.
In another aspect, the invention is a method for measuring a blood 2o parameter. The method includes passing through a conduit in an extracorporeal circuit with a blood monitor having a light source, a near sensor and a far sensor.
The light source emits a plurality of wavelengths through the conduit into the blood.
The light reflected by the blood is directed to the near sensor. The light reflected by the blood is also directed to the far sensor. The quantity of reflected light 2s received by the blood at the near sensor and the far sensor is measured at a plurality of wavelengths. The measured quantity of reflected light at the near sensor and the far sensor is used to calculate the desired blood parameter using a plurality of wavelengths.
In another aspect, the invention is a method for measuring a blood parameter using a clamp to mount optical fibers to the conduit. The method includes providing a blood monitor having a near sensor, a far sensor and a light source which are connected by optical fibers to a clamp. The clamp is mounted on the s conduit in a manner such that terminal ends of the optical fibers are held against the outer surface of the conduit. Light is emitted at a plurality of wavelengths through the conduit into the blood. The light reflected by the blood at a plurality of wavelengths is received by the sensors. The light received by the near and the far sensors is quantitated at a plurality of wavelengths. The values for blood to parameters are then calculated from the quantity of reflected light.
In another aspect, the invention is a clamp for positioning optical fibers against a conduit to measure reflected light. The clamp includes a body defining a cavity shaped to accept the conduit and a mating piece movably attached to the body. The mating piece is shaped so as to cooperate with the body to securedly 1s hold the conduit. The mating piece is preferably hingedly attached to the body. At least two optical fibers mounted in the body, wherein terminal ends of the optical fibers extend into the cavity. The body and mating piece cooperate to hold the conduit such that in a closed position the conduit is compressionally biased against the terminal ends of the optical fibers. The clamp can include a lock for 2o maintaining the mating piece in the closed position. The clamp can have the terminal ends of the optical fibers positioned co-axially along the flow path of blood in the conduit. The clamp can secure three optical fibers, a first fiber, a second fiber secured about 0.8mm from the first fiber and a third fiber secured about l.2mm from the light source.
25 In another aspect, the invention is a clamp for positioning optical fibers against a conduit for measuring blood parameters using transmitted light. The clamp includes a body defining a cavity shaped to accept conduit. At least one optical fiber is secured in the body with the terminal end of the optical fiber extending into the cavity. A mating piece movably attached to the body. The cavity and the mating piece shaped so as to cooperate in securing the conduit when in a closed position. At least two optical fibers are mounted in the mating piece such that terminal ends of the fibers extend into the are positioned opposite the cavity so as to receive light transmitted through the blood from an optical fiber in the cavity of the body. The terminal ends of the optical fibers are positioned such that they are compressionally biased against the conduit when the conduit is held in the clamp.
In another aspect, the invention is a method for calibrating a blood monitor.
The monitor to be calibrated having a light source and a spectrometer with at least one charge coupled device array which measures blood parameters in an extracorporeal circuit. The method including masking pixels of the charge coupled device array. A dark reference is measured from the masked pixels of the charge coupled device array. A light reference is measured using the light from the light source reflected by a diffuse reflective material. The values for reflected light are normalized using the measured light reference and the measured dark reference.
In another aspect, the invention is a method of regulating use of a medical monitor. The method for regulating uses includes providing a key encoded with data indicative of a pre-selected number of uses and providing firmware in the 2o monitor which recognizes the data encoded key. The firmware and the data encoded key are electrically connected wherein the data encoded key activates the monitor for the pre-selected number of uses. A use can include continuously running of the monitor for eight hours, removing of the clamp for a specified period of time or any other activity indicative of a complete cycle of use.
Alternatively, the method of regulating use of the medical monitor includes providing circuitry to disable the monitor and providing firmware in the monitor that can be programmed for a pre-selected number of uses. The firmware is coupled to the disabling circuitry in a manner so as to disable the monitor after the pre-selected number of uses.
Brief Description of the Drawings s Fig. 1 is a perspective view of a preferred embodiment of the blood monitor;
Fig. 2a is a perspective view of an embodiment of the clamp in the open position;
Fig. 2b is a perspective view of an embodiment of the clamp in the closed position;
1o Fig. 2c is a perspective view of an embodiment of the adapter insert;
Fig. 3a is an enlarged cross-sectional view from the top of an embodiment of the clamp;
Fig. 3b is an enlarged cross-sectional view from the front of an embodiment of the clamp;
~s Fig 3c is a detailed view of the terminal ends of the optical fibers;
Fig. 4 is a block diagram of an embodiment of the blood monitor's operation;
Fig. 5 is a perspective view of an embodiment of the calibration post; and Fig. 6 is a block diagram showing the method of operation of the key 2o reader.
Detailed Description of the Invention The present invention is a monitor or apparatus for monitoring blood parameters and utilizes a polychromatic light beam which is directed into blood.
The extent of absorption, refraction, scattering and reflection of the light is 2s determined by the chemistry and physical properties of the blood. Incident light is absorbed, refracted, scattered and reflected by the blood. At each wavelength, a fraction of incident light is either absorbed, scattered or reflected. This absorbed, scattered or reflected light can be detected by sensors in order to measure and monitor oxygen saturation, hematocrit, hemoglobin, oxyhemoglobin, deoxyhemoglobin, carboxy-hemoglobin, methoxy-hemoglobin, and bilirubin and further can determine cell counts for erythrocytes and platelets.
The diagram of Fig. 1 shows an embodiment of the instant invention used s for measuring blood parameters, in particular for measuring .oxygen saturation, hematocrit and hemoglobin. The diagram shows clamp 30 secured to conduit 10 of an extracorporeal circuit. Clamp 30 securely holds the ends of optical fibers contained in fiber optic cable 14. Conduit 10 can be any optically clear element of the extracorporeal circuit through which blood within the circuit passes, such as a 1o cuvette, but is preferably optically clear tubing or more preferably clear polyvinylchloride (PVC) tubing. An optical fiber directs light to the blood from a light source located in housing 11. A plurality of optical fibers receive light reflected from the blood and direct light to one or more spectrometers located in housing 11. Clamp 30 secures the ends of the optical fibers to the conduit 10 such that the blood flows through conduit 10 substantially perpendicular to the optical fibers. In a preferred embodiment, the housing includes a numeric display 21 displaying the values for oxygen saturation, hematocrit and hemoglobin concentration. In a more preferred embodiment, numeric display 21 is a monitor having five seven-segment LED's displaying the parameters. The housing can also 2o contain an alphanumeric display 22 to communicate information to the perfusionist regarding the status of the monitor and the patient. In a preferred embodiment, alphanumeric display 22 is a vacuum fluorescent display {VFD). Further, housing 18 preferably includes the controls for the operation and adjustment of the monitor and selection of the blood parameter to be displayed.
Figs. 2a, 2b and 2c show a preferred embodiment of conduit clamp 30.
Conduit clamp 30 is composed of a body 32 and a mating piece 34. Body 32 defines a cavity 36 shaped to secure conduit 10 of an extracorporeal circuit.
Mating piece 34 defines a cavity 38 and is attachable to body 32 such that the mating piece 34 can be in an open position, shown in Fig. 2a, or a closed position, shown in Fig. 2b. In a preferred embodiment mating piece 34 is hingedly attached to body 32 and is provided with a locking apparatus 40 to secure body 32 and mating piece s 34 in the closed position. Most preferably, locking apparatus 40 is a stainless steel short spring plunger and detent so clamp 30 is not accidentally removed from conduit 10. When in the closed position body cavity 36 and mating piece cavity cooperate to secure conduit 10.
In an alternative embodiment cavity 38 is provided with an adapter 42 allowing smaller diameter or alternatively shaped conduit to be secured in clamp 30.
The design of clamp 30 provides increased ambient light isolation and easy placement anywhere on the extracorporeal circuit. For example, the operator can place the clamp on conduit either upstream or downstream of the oxygenator allowing measurement of the parameters of venous or arterial blood, respectively.
1s In another alternative embodiment, not shown, a near optical fiber and a far optical fiber are mounted on a mating piece on the opposite side of conduit 10 from the light source such that the optical fibers are differentially spaced from the light source and detect light transmitted through the blood flowing through the conduit as opposed to reflected light. Most preferably, the mating piece is configured such 2o that, in the closed position, the ends of the optical fibers are biased against the conduit of the circuit. In order for the sensors to be able to pick up sufficient transmitted light so that the desired parameters can be measured, the conduit should be of a diameter small enough such that sufficient light from the light source is transmitted through the blood and received by the near and far sensors that are 2s differentially spaced from the light source. Additionally or alternatively, the light source's intensity could be increased such that light from Iight source is capable of penetrating the blood flowing through standard sized extracorporeal circuit conduit to reach the sensors mounted on the mating piece opposite the light source.
Figs. 3a, 3b and 3c show detailed cross sectional views of an embodiment of clamp 30. In this embodiment, a ferrule 50 securedly holds the terminal ends of three optical fibers. An optical fiber 15 is in optical communication with the light s source 16. A near optical fiber 17 is in optical communication with near sensor 18.
A far optical fiber 19 is in optical communication with far sensor 20.
Preferably, the ends of the optical fibers are positioned substantially coplanar with the end of ferrule 50. Further, the ends of the optical fibers are preferably polished such that light transmitted or received is not distorted by irregularities in the ends of the optical fibers. Ferrule 50 is securedly mounted in body 32 such that optical fiber 15, near optical fiber 17 and far optical fiber 19 are in optical communication with conduit 10. Clamp 30 positions ferrule 50 relative to conduit IO such that light transmitted from light source 16 passes through optical fiber 15 and conduit 10.
The path of light emitted from optical fiber 15 is preferably substantially 15 perpendicular to the flow of blood within conduit 10. The light reflected by the blood passes back through conduit 10 and is transmitted by near optical fiber 17 and far optical fiber 19 to near sensor 18 and far sensor 20, respectively. In a more preferred embodiment, the end of ferrule 50 extends through body 32 beyond the inner wall of cavity 36 such that conduit 10 held by clamp 30 is biased against the 2o end of the ferrule 50 as shown in Fig. 3a. This biased configuration assures that there is no space between conduit 10 and ferrule 50 and therefore, no disruption of the light path. In an alternative embodiment, not shown, ferrule 50 and body 32 are integrated into a single element securing optical fiber 15, near optical fiber 17 and far optical fiber 19.
2s Near optical fiber 17 and far optical fiber 19 receive light at different distances from optical fiber 15. The near and far optical fibers are positioned from between about 0.6mm to about 3.Omm from optical fiber 15 such that a sufficient amount of light is received by far optical fiber 19 to produce the data necessary to calculate the desired parameters. In a preferred embodiment, near optical fiber 17 receives light at a distance of about 0.8mm from optical fiber 15 and far optical fiber 19 receives light at a distance of about l.2mm from optical fiber 15. In a most preferred embodiment, the optical fibers are positioned axially along the s blood's flow path wherein, near optical fiber 17 is located 0.8mm upstream from optical fiber 15 and far optical fiber 19 is located l.2mm downstream from optical fiber 15.
The block diagram of Fig. 4 shows the mechanism of the monitor's operation. Light source 16 directs light into blood flowing through conduit 10.
1o The light is absorbed, refracted, scattered and reflected by the blood.
Reflected light is received by near optical fiber 17 and far optical fiber 19 and is transmitted to near sensor 18 and far sensor 20, respectively. The near and far sensors quantitate the light received at a plurality of wavelengths. The light's intensity is normalized at each of the plurality of wavelengths by the arithmetic circuit 25. The 15 arithmetic circuit 25 then uses the normalized intensities to calculate the values for the blood parameters and produce an output 24. In another embodiment, an additional optical fiber guides light from the light source to a silicone photodiode 27. Photodiode 27 provides an extra measure of safety in case of burnout of the light source as well as providing trending of light source's intensity.
2o In one embodiment, light source 16 directs a plurality of wavelengths between about 300nm to about 10,000nm and more preferably between about 405nm and about 1100nm into conduit 10. Most preferably, the light source 16 is a tungsten halogen bulb, although any bulb emitting a sufficient intensity of light over the desired spectrum could be used. In another embodiment, a plurality of light 2s sources each emitting discrete spectra, such as light emitting diodes (LEDs), are used to emit the desired wavelengths of light. The plurality of light sources are either combined or sequentially emitted and directed to a single point along the extracorporeal circuit using optical fiber 15.
In a preferred embodiment, near sensor 18 is a first channel of a two-channel spectrometer receiving light from near optical fiber 17 and far sensor 20 is a second channel of the spectrometer receiving light from far optical fiber 19. The first and second channels are separate optical blocks electronically connected as a single two-channel spectrometer. Alternatively, near sensor 18 could comprise a first spectrometer receiving light from near optical fiber 17 and the far sensor could comprise a second spectrometer receiving light from far optical fiber 19. In still another embodiment, the near and far sensors could share a single spectrometer having a single channel switching between and separately quantitating light received 1o from near optical fiber 17 and far optical fiber 19. Regardless of configuration, the sensors quantitate the amount of light received from near optical fiber 17 and far optical fiber 19 at a plurality of wavelengths and transmit the data to the arithmetic circuit 25. The arithmetic circuit 25 then calculates the values for oxygen saturation, hematocrit and hemoglobin concentration using the input from near is sensor 18 and far sensor 20.
Before using the monitor, a two-point calibration is performed. The two-point calibration establishes a light reference and a dark reference. The dark reference measures the electrical stability of the optical system. The dark reference is determined by measuring the output from masked pixels of the spectrometer's 2o CCD (charge coupled device) array. The light reference measures the intensity of the light source. The light reference is the intensity of reflected light received by the near and far optical fibers from a diffuse reflective material. The light reference is taken without tubing or other obstruction in the light path. The values for the light reference and a first dark reference are recorded and stored for data 25 normalization.
To perform a two-point calibration, clamp 30 is preferably mounted on a calibration post 60, shown in Fig. 5. Post 60 is shaped such that the post can be seeuredly held by clamp 30. Post 60 defines a cavity 64 in which diffuse reflective material 62 is located. The cavity provides an unobstructed path for light emitted from source fiber 15 and reflected from diffuse reflective material 62 to be received by near optical fiber 17 and far optical fiber 19. Diffuse reflective material 62 is preferably a sputtered gold mirror or a material with similar reflective properties 5 such as that commercially available as Spectralon~ from Labsphere , Inc.
located in North Sutton, New Hampshire. In a preferred embodiment, one or more alignment pins 65 are provided on calibration post 60 such that the alignment pins cooperate with cavities on clamp 30 to secure diffuse reflective material 62 in the proper orientation for calibration. When clamp 30 is mounted on post 60, optical fiber 15 io is oriented above the cavity such that light is emitted in a direction substantially perpendicular to the plane of the reflective material 62. In an alternative embodiment, mating piece cavity 38 is positioned opposite ferrule 50 and contains a calibrated diffuse reflective material for measuring the light reference. In a most preferred embodiment, during a two-point calibration, the monitor senses when 15 either the angle of incidence or the intensity of the light reference are incorrect and displays an error message on the alphanumeric display.
In operation, light source 16 is turned on and clamp 30 is placed on post 60.
After emissions from light source 16 have stabilized the monitor measures light 2o received by near optical fiber 17 and far optical fiber 19 and stores the measurement as the light reference for near sensor 16 and far sensor 18, respectively. The CCD
array's masked pixels for both near sensor 16 and far sensor 18 are also measured and stored during calibration to establish a dark reference. After the two-point calibration is performed the clamp is placed on the conduit of the extracorporeal circuit.
The data from the two-point calibration is used to normalize data used to calculate the blood parameters. The data is normalized pursuant to the formula:
~Inormalized~6W16-ldark~t=t~Uhigh~6-Idark~t=0 ~EQuation 1~
wherein, "I" is the intensity of light, t=0 is the time of calibration, t=t is the time at which intensity is measured, and 6 is a wavelength at which the reflectance is measured. A first dark reference, Idarx, is obtained at t=0. The light reference, hight6~ is also obtained at t=0 after stabilization of the intensity of the light source's s emission spectra. The light and first dark references are used in Equation 1 to normalize the data and remain constant until another two-point calibration is initiated. In finding the normalized intensity, Ino,."~,~,;~ed6, the arithmetic circuit 25 receives the input of the reflected intensity, I6, at a plurality of wavelengths. The reflected intensity is the intensity of light received by near optical fiber 17 and far optical fiber 19 at time t=t after transmission of light through the conduit, reflectance of light by the blood and transmission back through the conduit to the sensors. A second dark reference, Nark, is also taken at time t=t by again sampling the masked pixels of the CCD array. The second dark reference measures the electrical stability of the optical system at the time t=t and may vary unlike the first 1s dark reference. The normalized intensity, Ino~,;~ea6, resulting from Equation 1 is used by the arithmetic circuit 25 to calculate the desired blood parameters.
The arithmetic circuit 25 preferably uses a third order polynomial equation to calculate the desired blood parameters. The variables input into the equation to calculate hematocrit, hemoglobin and oxygen saturation are ratios of the normalized 2o intensities of a plurality of wavelengths in a range between 405nm and 999nm received by the near and far sensors. The individual third order polynomial equations used for calculating oxygen saturation, hematocrit and total hemoglobin are established using non-linear mufti-variable regression analysis. The regression analysis can be accomplished using a standard statistical program, such as that 2s commercially available as Statistics from StatSoft'~, Inc. located in Tulsa, Oklahoma. The data for regression analysis is obtained by measuring the reflection of blood with defined parameters at the selected wavelengths with an acceptable laboratory instrument or other suitably accurate means. To assure accurate measurements a total of at least four wavelengths are input into the equation.
At least one of the wavelengths used in the equation should be selected from the range of isobestic wavelengths for hemoglobin. The isobestic wavelengths for hemoglobin fall in the range between 802nm and 815nm. Preferably the wavelengths are s selected from the group consisting of 680nm, 710nm, 740nm, 760nm, 802nm, 803nm, 805nm, 810nm, 815nm, 825nm, 827nm, 830nm, 850nm, 880nm, 900nm, 935nm, and 999nm. The wavelengths input into the arithmetic apparatus are selected on the basis of spectral absorption curves of the blood parameters.
In a most preferred embodiment, the third order polynomial for measuring the oxygen saturation (Sat) is the formula:
Sat = A(n680nm/n815nm)3 + B(n680nm/n815nm)2 + C(n680nm/n815nm) + D(n680nm/n815nm)-' + E(n680nm/n815nm)~' + F(n710nm/n740nm)3 +
G(n710nm/n740nm)2 + H(n710nm/n740nm) + I{n710nm/n740nm)-' +
J(n710nm/n740nm) ' + L(n760nm/n815nm)3 +M(n760nm/n815nm)2 +
1s N(n760nm/n815nm) + O(n760nm/n815nm)-1 + P(n760nm/n8l5nm) -2 +
T(f680nm/f815nm)3 +U(f680nm/f815nm)2 + V(f680nm/f815nm) +
W(f680nm/f815nm)-' + X(f680nm/f815nm) -2 + Y(f710nm/f740nm)3 +
Z(f710nm/f740nm)2 + AA(f710nm/f740nm) + BB(f710nm/f740nm)-1 +
CC(f7l0nm/f740nm)-2 + DD(f760nm/f815nm)3 + EE(f760nm/f815nm)2 +
2o FF(f760nm/f815nm) +GG(f760nm/f815nm)-' + HH(f760nm/f815nm)-2 +
II(n815nm/f810nm)3 + JJ(n815nm/f810nm)2 + KK(n815nm/f810nm) + LL
wherein A to LL are constants established by non-linear mufti-variable regression analysis and "n" designates the normalized intensity of light received by the near sensor at the respective wavelength and "f" designates the normalized intensity of 2s light received by the far sensor at the respective wavelength.
In a most preferred embodiment, the arithmetic means bifurcates the calculation of hemoglobin and hematocrit between two formulas dependent on the concentration of total hemoglobin (Hgb) and the hematocrit (Hct) in the sample being monitored. The arithmetic means bifurcates the calculation because the curves generated by the third order polynomial equations are non-monotonic curves over certain ranges of total hemoglobin and hematocrit. Therefore, two separate s equations were developed wherein the curves are monotonic over alternative ranges.
The first equation is monotonic over a low range corresponding to a Hct of less than twenty five or alternatively, a Hgb of less than nine. The second equation is monotonic over a high range corresponding to a Hct of greater than or equal to twenty five or alternatively, a Hgb of greater than or equal to nine. If the value falls into the low range the arithmetic circuit 25, most preferably, uses the formula:
Hgb or Hct = A(n815nm/f810nm)3 + B(n815nm/f810nm)2 +
C(n815nm/f810nm) + D(n815nm/f810nm)-' + E(n815nrn/f810nm)-2 +
F(n850nm/f825nm)~ + G(n850nm/n825nm)2 + H(n850nm/f825nm) +I(n850nm/f825nm)-' + J(n850nm/f825nm)-2 + O(n880nm/f827nm)3 +
~s P(n880nm/f827nm)2 + Q(n880nm/f827nm) + R(n880nm/f827nm)-~ +
S(n880nm/f827nm)-2 + U(n900nm/f830nm)3 + V(n900nm/f830nm)2 +
W(n900nm/f830nm) + X(n900nm/f830nm) -' +Y(n900nm/F830nm)-Z +
Z(n999nm/f935nm)3 + AA(n999nm/f935nm)2 + BB(n999nm/f935nm) +
CC(n999nm/f935nm)-' + DD(n999nm/f935nm)-' + EE(n760nm/n815nm)3 +
2o FF(n760nm/n815nm)2 + GG(n760nm/n815nm) + HH
If the values fall into the high range, the arithmetic circuit 25 most preferably uses the formula:
Hgb or Hct = A(n802nmN'/f802nmD')3 + B(n802nmN'/f802nmD')2 +
C(n802nmN'/f802nmD') + D(n802nmN'/f802nmD')-' +
2s E(n802nmN'/f802nmD')-2 + I(n803nmN2/f803nmDa)s + J(n803nmN2f803nmDa)a + K(n803nmN2/f803nmD2) + L(n803nmN2/f803nmD2)-' +
M(n803nmN2/f803nmDa)-2 + O(n805nmN3/f802nm"2)3 +
P(n805nmN3/f802nmD3)z + Q(n805nmN3/f802nmD3) +
R(nBOSnmN3/f8O2nmD3)~' + S(nBOSnmN3/f8O2nmp3)-2 +
U(n8lOnmN4/f8O3nmp4)3 + V(n8lOnmN4/f8O3nmD4)a +
W(n8lOnmN4/f8O3nmD4) + X(n8lOnmN4/f8O3nmDa) -i +
Y(n810nmN4/f803nmDa)-2 + FF(n760nm/n815nm)3 + GG(n760nm/n815nm)2 + HH(n760nm/n815nm) + II
wherein A to II, N 1 to N4, and D 1 to D4 are constants established independently for Hct and Hgb by non-linear mufti-variable regression analysis and "n"
designates the normalized intensity of light received by the near sensor at the respective wavelength and "f" designates the normalized intensity of light received 1o by the far sensor at the respective wavelength.
Arithmetic circuit 25 provides the results of these calculations as output 24.
Preferably, the values generated by the arithmetic circuit 25 are displayed on numeric display 20. In a most preferred embodiment, the user selects alternatively whether Hct or Hgb will be calculated and displayed.
A one-point calibration can also be performed on the monitor in order to adjust the output to equal that of a laboratory instrument and thus, increase the accuracy of the displayed measurement. To perform a one-point calibration the user draws a blood sample from the extracorporeal circuit while substantially simultaneously storing the values for the parameters being measured by the monitor.
2o The user then measures the parameters on a separate apparatus and inputs the values into the monitor. The separate apparatus is preferably a laboratory instrument or other suitably accurate apparatus. The monitor's software adjusts the parameter values by adding or subtracting an offset value, based on the difference between apparatus and monitor values.
The monitor can be further provided with an apparatus for regulating the number of uses. Preferably, the apparatus comprises a data encoded key, a receptacle on the monitor for receiving and reading the key, and firmware recognizing the encoded data. In operation, the electronic key encoded with erasable data recognized by the firmware as a number of uses. The key is inserted into the receptacle and the firmware reads the data encoded on the key. The firmware then prompts the user to load all or a lesser number of uses. The total number of uses loaded by the user is subtracted from the key and loaded into the monitor. Each time the monitor is used the arithmetic circuit reduces the number of 5 uses left on the monitor by one. A use is defined by the manufacturer. In a most preferred embodiment, the use comprises continuous operation for eight hours or removal from the conduit for a set period of time. A suitable method for such regulation is shown diagrammatically in Fig. 6.
Claims (29)
1. An apparatus for measuring blood parameters through conduit of an extracorporeal circuit, comprising:
a light source which transmits light at a plurality of wavelengths to the conduit;
a near sensor which senses light at a plurality of wavelengths connected to receive light a first distance from the light source which has been one of reflected and transmitted by the blood, wherein signals generated by the near sensor are indicative of the intensity of the sensed light at a plurality of wavelengths;
a far sensor which senses light at a plurality of wavelengths connected to receive light a second distance from the light source which has been one of reflected and transmitted by the blood, wherein signals generated by the far sensor are indicative of the intensity of light at a plurality of wavelengths; and an arithmetic circuit connected to receive the signals from the near sensor and the far sensor and wherein the signals are used to calculate a parameter of blood and to generate an output signal indicative thereof.
a light source which transmits light at a plurality of wavelengths to the conduit;
a near sensor which senses light at a plurality of wavelengths connected to receive light a first distance from the light source which has been one of reflected and transmitted by the blood, wherein signals generated by the near sensor are indicative of the intensity of the sensed light at a plurality of wavelengths;
a far sensor which senses light at a plurality of wavelengths connected to receive light a second distance from the light source which has been one of reflected and transmitted by the blood, wherein signals generated by the far sensor are indicative of the intensity of light at a plurality of wavelengths; and an arithmetic circuit connected to receive the signals from the near sensor and the far sensor and wherein the signals are used to calculate a parameter of blood and to generate an output signal indicative thereof.
2. An apparatus as in claim 1, wherein the blood parameters are at least one of oxygen saturation, hematocrit and hemoglobin concentration.
3. An apparatus as in claim 1, wherein the light source emits wavelengths between 450nm and 1150nm.
4. An apparatus as in claim 1, wherein the light source is a tungsten halogen bulb.
5. An apparatus as in claim 1, wherein the near sensor is a first charge coupled device and the far sensor is a second charge coupled device of a single two-channel spectrometer.
6. An apparatus as in claim 1, wherein the near sensor is a first spectrometer and the far sensor is a second spectrometer.
7. An apparatus as in claim 1, wherein the blood parameter being measured is oxygen saturation and wherein the arithmetic circuit derives the blood oxygen saturation from the ratios of reflected light at wavelengths between 660nm and 815nm in accordance with the formula:
oxygen saturation = A(n680nm/n815nm)3 + B(n680nm/n815nm)2 +
C(n680nm/n815nm) + D(n680nm/n815nm)-1 + E(n680nm/n815nm)-2 +
F(n710nm/n740nm)3 + G(n710nm/n740nm)2 + H(n710nm/n740nm) +
I(n710nm/n740nm)-1 + J(n710nm/n740nm)-2 + L(n760nm/n815nm)3 +M(n760nm/n815nm)2 + N(n760nm/n815nm) + O(n760nm/n815nm)-1 +
P(n760nm/n815nm)-2 + T(f680nm/f815nm)3 +U(f680nm/f815nm)2 +
V(f680nm/f815nm) + W(f680nm/f815nm)-1 + X(f680nm/f815nm)-2 +
Y(f710nm/f740nm)3 + Z(f710nm/f740nm)2 + AA(f710nm/f740nm) +
BB(f710nm/f740nm)-1 + CC(f710nm/f1740nm)-2 + DD(f760nm/f815nm)3 +
EE(f760nm/f815nm)2 + FF(f760nm/f815nm)+GG(f760nm/f815nm)-1 +
HH(f760nm/f815nm)-2 + II(n815nm/f810nm)3 + JJ(n815nm/f810nm)2 +
KK(n815nm/f810nm) + LL
wherein A to GG are constants, n designates the reflectance detected by the near sensor, and f designates the reflectance detected by the far sensor.
oxygen saturation = A(n680nm/n815nm)3 + B(n680nm/n815nm)2 +
C(n680nm/n815nm) + D(n680nm/n815nm)-1 + E(n680nm/n815nm)-2 +
F(n710nm/n740nm)3 + G(n710nm/n740nm)2 + H(n710nm/n740nm) +
I(n710nm/n740nm)-1 + J(n710nm/n740nm)-2 + L(n760nm/n815nm)3 +M(n760nm/n815nm)2 + N(n760nm/n815nm) + O(n760nm/n815nm)-1 +
P(n760nm/n815nm)-2 + T(f680nm/f815nm)3 +U(f680nm/f815nm)2 +
V(f680nm/f815nm) + W(f680nm/f815nm)-1 + X(f680nm/f815nm)-2 +
Y(f710nm/f740nm)3 + Z(f710nm/f740nm)2 + AA(f710nm/f740nm) +
BB(f710nm/f740nm)-1 + CC(f710nm/f1740nm)-2 + DD(f760nm/f815nm)3 +
EE(f760nm/f815nm)2 + FF(f760nm/f815nm)+GG(f760nm/f815nm)-1 +
HH(f760nm/f815nm)-2 + II(n815nm/f810nm)3 + JJ(n815nm/f810nm)2 +
KK(n815nm/f810nm) + LL
wherein A to GG are constants, n designates the reflectance detected by the near sensor, and f designates the reflectance detected by the far sensor.
8. An apparatus as in claim 1, wherein the blood parameter being measured is one of hemoglobin concentration and hematocrit and wherein the arithmetic circuit derives one of hemoglobin concentration and hematocrit from the ratios of reflected light at a plurality of wavelengths between 760nm and 999nm in accordance with the formula:
hemoglobin and hematocrit = A(n815nm/f810nm)3 + B(n815nm/f810nm)2 + C(n815nm/f810nm) + D(n815nm/f810nm)-1 + E(n815nm/f810nm)-2 +
F(n850nm/f825nm)3 + G(n850nm/n825nm)2 + H(n850nm/f825nm) +I(n850nm/f825nm)-1 + J(n850nm/f825nm)-2 + O(n880nm/f827nm)3 +
P(n880nm/f827nm)2 + Q(n880nm/f827nm) + R(n880nm/f827nm)-1 +
S(n880nm/f827nm)-2 + U(n900nm/f830nm)3 + V(n900nm/f830nm)2 +
W(n900nm/f830nm) + X(n900nm/f830nm)-1 +Y(n900nm/F830nm)-2 +
Z(n999nm/f935nm)3 + AA(n999nm/f935nm)2 + BB(n999nm/f935nm) +
CC(n999nm/f935nm)-1 + DD(n999nm/f935nm)-2 + EE(n760nm/n815nm)3 +
FF(n760nm/n815nm)2 + GG(n760nm/n815nm) + HH
when blood hemoglobin concentration is less than 9 or hematocrit is less than 25, and hemoglobin and hematocrit = A(n802nm N1/f802nm D1)3 +
B(n802nm N1/f802nm D1)2 + C(n802nm N1/f802nm D1) +
D(n802nm N1/f802nm D1)-1 + E(n802nm N1/f802nm D1)-2 +
I(n803nm N2/f803nm D2)3 + J(n803nm N2f803nm D2)a + K(n803nm N2/f803nm D2) + L(n803nm N2/f803nm D2)-1 + M(n803nm N2/f803nm D2)-2 +
O(n805nm N3/f802nm D2)3 + P(n805nm N3/f802nm D3)2 +
Q(n805nm N3/f802nm D3) + R(n805nm N3/f802nm D3)-1 +
S(n805nm N3/f802nm D3)-2 + U(n810nm N4/f803nm D4)3 +
V(n810nm N4/f803nm D4)2 + W(n810nm N4/f803nm D4) +
X(n810nm N4/f803nm D4)-1 + Y(n810nm N4/f803nm D4)-2 +
FF(n760nm/n815nm)3 + GG(n760nm/n815nm)2 + HH(n760nm/n815nm) + II
when blood hemoglobin concentration is greater than or equal to 9 or hematocrit is greater than or equal to 25 and wherein A to II are constants, n designates the reflectance sensed by the near sensor, and f designates the reflectance sensed by the far sensor.
hemoglobin and hematocrit = A(n815nm/f810nm)3 + B(n815nm/f810nm)2 + C(n815nm/f810nm) + D(n815nm/f810nm)-1 + E(n815nm/f810nm)-2 +
F(n850nm/f825nm)3 + G(n850nm/n825nm)2 + H(n850nm/f825nm) +I(n850nm/f825nm)-1 + J(n850nm/f825nm)-2 + O(n880nm/f827nm)3 +
P(n880nm/f827nm)2 + Q(n880nm/f827nm) + R(n880nm/f827nm)-1 +
S(n880nm/f827nm)-2 + U(n900nm/f830nm)3 + V(n900nm/f830nm)2 +
W(n900nm/f830nm) + X(n900nm/f830nm)-1 +Y(n900nm/F830nm)-2 +
Z(n999nm/f935nm)3 + AA(n999nm/f935nm)2 + BB(n999nm/f935nm) +
CC(n999nm/f935nm)-1 + DD(n999nm/f935nm)-2 + EE(n760nm/n815nm)3 +
FF(n760nm/n815nm)2 + GG(n760nm/n815nm) + HH
when blood hemoglobin concentration is less than 9 or hematocrit is less than 25, and hemoglobin and hematocrit = A(n802nm N1/f802nm D1)3 +
B(n802nm N1/f802nm D1)2 + C(n802nm N1/f802nm D1) +
D(n802nm N1/f802nm D1)-1 + E(n802nm N1/f802nm D1)-2 +
I(n803nm N2/f803nm D2)3 + J(n803nm N2f803nm D2)a + K(n803nm N2/f803nm D2) + L(n803nm N2/f803nm D2)-1 + M(n803nm N2/f803nm D2)-2 +
O(n805nm N3/f802nm D2)3 + P(n805nm N3/f802nm D3)2 +
Q(n805nm N3/f802nm D3) + R(n805nm N3/f802nm D3)-1 +
S(n805nm N3/f802nm D3)-2 + U(n810nm N4/f803nm D4)3 +
V(n810nm N4/f803nm D4)2 + W(n810nm N4/f803nm D4) +
X(n810nm N4/f803nm D4)-1 + Y(n810nm N4/f803nm D4)-2 +
FF(n760nm/n815nm)3 + GG(n760nm/n815nm)2 + HH(n760nm/n815nm) + II
when blood hemoglobin concentration is greater than or equal to 9 or hematocrit is greater than or equal to 25 and wherein A to II are constants, n designates the reflectance sensed by the near sensor, and f designates the reflectance sensed by the far sensor.
9. An apparatus as in claim 1, further comprising a source optical fiber connected to transmit light to the conduit from the light source, the source optical fiber having a first end connected to the light source and a second terminal end connected adjacent the conduit, the near sensor receives light from a near optical fiber, the near optical fiber having a first end connected to the near sensor and a second terminal end connected adjacent the conduit, and the far sensor receives light from a far optical fiber, the far optical fiber having a first end connected to the far sensor and a second terminal end connected adjacent the conduit.
10. An apparatus as in claim 9, further comprising a clamp for mounting a terminal end of the source optical fiber, a terminal end of the near optical fiber and a terminal end of the far optical fiber such that the source fiber, the near optical fiber and the far optical fiber are in optical communication with the conduit of the extracorporeal circuit;
11. An apparatus as in claim 9, wherein a terminal end of the near optical fiber is positioned about 0.8mm from a terminal end of the source optical fiber and a terminal end of the far optical fiber is positioned about l.2mm from the terminal end of source optical fiber.
12. An apparatus as in claim 9, wherein a terminal end of the near optical fiber, a terminal end of the far optical fiber and a terminal end of the source optical fiber are positioned co-axially along the flow path of blood in the conduit.
13. An apparatus as in claim 10, wherein the clamp secures the terminal ends of the optical fibers so as to bias the terminal ends of the optical fibers against the conduit.
14. An apparatus for measuring blood parameters through conduit of an extracorporeal circuit, comprising:
means for emitting light at a plurality of wavelengths into blood flowing through the conduit;
near means for receiving light reflected from the blood;
far means for receiving light reflected from the blood, wherein the far receiving means and near receiving means are connected to receive reflected light at positions which are differentially spaced from the point where light is emitted into the conduit;
means for generating signals indicative of the intensity at a plurality of wavelengths of light received at a plurality of wavelengths by the near receiving means and far receiving means; and means for calculating receiving the signals from the signal generating means wherein, the calculating means calculates blood parameters and generates an output signal indicative thereof.
means for emitting light at a plurality of wavelengths into blood flowing through the conduit;
near means for receiving light reflected from the blood;
far means for receiving light reflected from the blood, wherein the far receiving means and near receiving means are connected to receive reflected light at positions which are differentially spaced from the point where light is emitted into the conduit;
means for generating signals indicative of the intensity at a plurality of wavelengths of light received at a plurality of wavelengths by the near receiving means and far receiving means; and means for calculating receiving the signals from the signal generating means wherein, the calculating means calculates blood parameters and generates an output signal indicative thereof.
15. An apparatus as in claim 14, wherein the blood parameters are at least one of oxygen saturation, hematocrit and hemoglobin concentration.
16. A method for measuring a parameter of blood passing through conduit in an extracorporeal circuit with a blood monitor having a light source, a near sensor and a far sensor, the method comprising:
directing a plurality of wavelengths from the light source through the conduit into the blood;
directing light reflected by the blood through the conduit to the near sensor;
directing light reflected by the blood through the conduit to the far sensor;
measuring the light reflected by the blood to the near sensor and the far sensor at a plurality of wavelengths; and calculating the blood parameter using the quantity of reflected light detected at a plurality of wavelengths by the near sensor and the far sensor.
directing a plurality of wavelengths from the light source through the conduit into the blood;
directing light reflected by the blood through the conduit to the near sensor;
directing light reflected by the blood through the conduit to the far sensor;
measuring the light reflected by the blood to the near sensor and the far sensor at a plurality of wavelengths; and calculating the blood parameter using the quantity of reflected light detected at a plurality of wavelengths by the near sensor and the far sensor.
17. A method as in claim 16, wherein the blood parameter is at least one of oxygen saturation, hemoglobin concentration and hematocrit.
18. A method for measuring blood parameters through a conduit, comprising:
providing a blood monitor including a near sensor, a far sensor and a light source which are connected by optical fibers to a clamp;
mounting the clamp on the conduit in a manner such that terminal ends of the optical fibers are held against the outer surface of the conduit;
emitting light at a plurality of wavelengths through the conduit into the blood;
receiving light at a plurality of wavelengths reflected by the blood;
quantitating the light reflected at the near sensor and the far sensor at a plurality of wavelengths; and calculating a blood parameter from the quantity of reflected light.
providing a blood monitor including a near sensor, a far sensor and a light source which are connected by optical fibers to a clamp;
mounting the clamp on the conduit in a manner such that terminal ends of the optical fibers are held against the outer surface of the conduit;
emitting light at a plurality of wavelengths through the conduit into the blood;
receiving light at a plurality of wavelengths reflected by the blood;
quantitating the light reflected at the near sensor and the far sensor at a plurality of wavelengths; and calculating a blood parameter from the quantity of reflected light.
19. A clamp for positioning optical fibers against a conduit for measuring blood parameters, comprising:
a body defining a cavity shaped to accept the conduit;
at least two optical fibers mounted in the body, wherein terminal ends of the optical fibers extend into the cavity; and a mating piece movably attached to the body shaped so as to cooperate with the body to securedly hold the conduit such that in a closed position the conduit is compressionally biased against the terminal ends of the optical fibers.
a body defining a cavity shaped to accept the conduit;
at least two optical fibers mounted in the body, wherein terminal ends of the optical fibers extend into the cavity; and a mating piece movably attached to the body shaped so as to cooperate with the body to securedly hold the conduit such that in a closed position the conduit is compressionally biased against the terminal ends of the optical fibers.
20. A clamp as in claim 19, wherein the mating piece is hingedly attached to the body.
21. A clamp as in claim 19, further comprising a lock for maintaining the mating piece in the closed position.
22. A clamp as in claim 19, wherein a terminal ends of the optical fibers are positioned co-axially along the flow path of blood in the conduit.
23. A clamp as in claim 19, securing three optical fibers, a first fiber, a second fiber secured about 0.8mm from the first fiber and a third fiber secured about 1.2mm from the light source.
24. A clamp for positioning optical fibers against a conduit for measuring blood parameters, comprising:
a body defining a cavity shaped to accept the conduit;
at least one optical fiber secured in the body wherein the terminal end of the optical fiber extends into the cavity; and a mating piece defining a cavity and having at least two optical fibers secured in the body wherein the terminal ends of the optical fibers extend into the cavity wherein the mating piece is movably attached to the body so as to cooperate with the body to securedly hold the conduit such that in a closed position the conduit is compressionally biased against the terminal ends of the optical fibers.
a body defining a cavity shaped to accept the conduit;
at least one optical fiber secured in the body wherein the terminal end of the optical fiber extends into the cavity; and a mating piece defining a cavity and having at least two optical fibers secured in the body wherein the terminal ends of the optical fibers extend into the cavity wherein the mating piece is movably attached to the body so as to cooperate with the body to securedly hold the conduit such that in a closed position the conduit is compressionally biased against the terminal ends of the optical fibers.
25. A method for calibrating a blood monitor having a light source and a spectrometer with at least one charge coupled device array which measures blood parameters in an extracorporeal circuit, the method comprising:
masking pixels of the charge coupled device array;
measuring a dark reference from the masked pixels of the charge coupled device array;
measuring a light reference using the light from the light source reflected by a diffuse reflective material; and normalizing the values for reflected light using the measured light reference and the measured dark reference.
masking pixels of the charge coupled device array;
measuring a dark reference from the masked pixels of the charge coupled device array;
measuring a light reference using the light from the light source reflected by a diffuse reflective material; and normalizing the values for reflected light using the measured light reference and the measured dark reference.
26. A method of regulating use of a medical monitor, comprising:
providing a key encoded with data indicative of a pre-selected number of uses;
providing firmware in the monitor which recognizes the data encoded key; and electrically connecting the firmware and the data encoded key wherein the data encoded key activates the monitor for the preselected number of uses.
providing a key encoded with data indicative of a pre-selected number of uses;
providing firmware in the monitor which recognizes the data encoded key; and electrically connecting the firmware and the data encoded key wherein the data encoded key activates the monitor for the preselected number of uses.
27. A method as in claim 26, wherein a use comprises continuous running of the monitor for eight hours.
28. A method as in claim 26, wherein a use comprises removal of the clamp for a specified period of time.
29. A method of regulating use of a medical monitor, comprising:
providing circuitry to disable the monitor;
providing firmware in the monitor that can be programmed for a pre-selected number of uses; and coupling the firmware to the disabling circuitry in a manner so as to disable the monitor after the pre-selected number of uses.
providing circuitry to disable the monitor;
providing firmware in the monitor that can be programmed for a pre-selected number of uses; and coupling the firmware to the disabling circuitry in a manner so as to disable the monitor after the pre-selected number of uses.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/186,997 US6144444A (en) | 1998-11-06 | 1998-11-06 | Apparatus and method to determine blood parameters |
| US09/186,997 | 1998-11-06 | ||
| PCT/US1999/025733 WO2000028322A1 (en) | 1998-11-06 | 1999-11-01 | Apparatus and method to determine blood parameters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2346074A1 true CA2346074A1 (en) | 2000-05-18 |
Family
ID=22687196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002346074A Abandoned CA2346074A1 (en) | 1998-11-06 | 1999-11-01 | Apparatus and method to determine blood parameters |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6144444A (en) |
| EP (1) | EP1125126A4 (en) |
| JP (1) | JP2002529174A (en) |
| AU (1) | AU764970B2 (en) |
| CA (1) | CA2346074A1 (en) |
| WO (1) | WO2000028322A1 (en) |
Families Citing this family (138)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6018673A (en) | 1996-10-10 | 2000-01-25 | Nellcor Puritan Bennett Incorporated | Motion compatible sensor for non-invasive optical blood analysis |
| US8409846B2 (en) | 1997-09-23 | 2013-04-02 | The United States Of America As Represented By The Department Of Veteran Affairs | Compositions, methods and devices for maintaining an organ |
| SE9804142D0 (en) * | 1998-11-30 | 1998-11-30 | Gambro Ab | Method and device for providing a signal |
| US6675031B1 (en) | 1999-04-14 | 2004-01-06 | Mallinckrodt Inc. | Method and circuit for indicating quality and accuracy of physiological measurements |
| US6624888B2 (en) * | 2000-01-12 | 2003-09-23 | North Dakota State University | On-the-go sugar sensor for determining sugar content during harvesting |
| PT2322085E (en) | 2000-04-17 | 2014-06-23 | Covidien Lp | Pulse oximeter sensor with piece-wise function |
| US8224412B2 (en) | 2000-04-17 | 2012-07-17 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with piece-wise function |
| US6748254B2 (en) | 2001-10-12 | 2004-06-08 | Nellcor Puritan Bennett Incorporated | Stacked adhesive optical sensor |
| CA2359178A1 (en) * | 2001-10-16 | 2003-04-16 | Abb Bomem Inc. | On-line optical analysis of a substance through a conduit section of a process line |
| JP4129867B2 (en) | 2002-07-18 | 2008-08-06 | 日機装株式会社 | Hematocrit sensor |
| US7190986B1 (en) | 2002-10-18 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Non-adhesive oximeter sensor for sensitive skin |
| JP2004298572A (en) * | 2003-04-01 | 2004-10-28 | Aruze Corp | Blood fatigue degree sensor |
| US7326576B2 (en) * | 2003-04-09 | 2008-02-05 | Prescient Medical, Inc. | Raman spectroscopic monitoring of hemodialysis |
| ITMI20031715A1 (en) * | 2003-09-05 | 2005-03-06 | Dideco Spa | CONTROL DEVICE IN THE DIFFERENTIATED COLLECTION OF THE |
| US7060018B2 (en) | 2003-09-11 | 2006-06-13 | Cobe Cardiovascular, Inc. | Centrifuge apparatus for processing blood |
| US8182521B2 (en) | 2003-09-24 | 2012-05-22 | Dynatherm Medical Inc. | Methods and apparatus for increasing blood circulation |
| US7160316B2 (en) | 2003-09-24 | 2007-01-09 | Dynatherm Medical, Inc. | Methods and apparatus for adjusting body core temperature |
| JP2005274568A (en) * | 2004-03-22 | 2005-10-06 | Spectromedical Inc | Spectroscopic method and apparatus for total hemoglobin measurement |
| US8304181B2 (en) | 2004-10-07 | 2012-11-06 | Transmedics, Inc. | Method for ex-vivo organ care and for using lactate as an indication of donor organ status |
| US9055740B2 (en) | 2004-10-07 | 2015-06-16 | Transmedics, Inc. | Systems and methods for ex-vivo organ care |
| US9301519B2 (en) | 2004-10-07 | 2016-04-05 | Transmedics, Inc. | Systems and methods for ex-vivo organ care |
| US7688440B2 (en) | 2005-01-27 | 2010-03-30 | Prescient Medical, Inc. | Raman spectroscopic test strip systems |
| US7524671B2 (en) | 2005-01-27 | 2009-04-28 | Prescient Medical, Inc. | Handheld raman blood analyzer |
| US7651851B2 (en) | 2005-01-27 | 2010-01-26 | Prescient Medical, Inc. | Handheld Raman body fluid analyzer |
| US8251907B2 (en) | 2005-02-14 | 2012-08-28 | Optiscan Biomedical Corporation | System and method for determining a treatment dose for a patient |
| ITMI20050866A1 (en) * | 2005-05-13 | 2006-11-14 | Marco Ranucci | MONITORING SYSTEM FOR CARDIAC SURGERY INTERVENTIONS WITH CARDIOPOLMONARY BYPASS |
| US9078428B2 (en) | 2005-06-28 | 2015-07-14 | Transmedics, Inc. | Systems, methods, compositions and solutions for perfusing an organ |
| US7657295B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US7590439B2 (en) | 2005-08-08 | 2009-09-15 | Nellcor Puritan Bennett Llc | Bi-stable medical sensor and technique for using the same |
| US7657294B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Compliant diaphragm medical sensor and technique for using the same |
| US20070060808A1 (en) | 2005-09-12 | 2007-03-15 | Carine Hoarau | Medical sensor for reducing motion artifacts and technique for using the same |
| US7899510B2 (en) | 2005-09-29 | 2011-03-01 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US8092379B2 (en) | 2005-09-29 | 2012-01-10 | Nellcor Puritan Bennett Llc | Method and system for determining when to reposition a physiological sensor |
| US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
| US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US8062221B2 (en) | 2005-09-30 | 2011-11-22 | Nellcor Puritan Bennett Llc | Sensor for tissue gas detection and technique for using the same |
| US7555327B2 (en) | 2005-09-30 | 2009-06-30 | Nellcor Puritan Bennett Llc | Folding medical sensor and technique for using the same |
| US7483731B2 (en) | 2005-09-30 | 2009-01-27 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US7486979B2 (en) | 2005-09-30 | 2009-02-03 | Nellcor Puritan Bennett Llc | Optically aligned pulse oximetry sensor and technique for using the same |
| US7881762B2 (en) | 2005-09-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
| US8233954B2 (en) | 2005-09-30 | 2012-07-31 | Nellcor Puritan Bennett Llc | Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same |
| US7787947B2 (en) * | 2006-03-31 | 2010-08-31 | Medtronic, Inc. | Method and apparatus for using an optical hemodynamic sensor to identify an unstable arrhythmia |
| CA2881613C (en) | 2006-04-19 | 2017-11-14 | Stanley Kyi | Systems and methods for ex vivo organ care |
| US8073518B2 (en) | 2006-05-02 | 2011-12-06 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
| DE102006029899B4 (en) * | 2006-06-29 | 2009-06-04 | Fresenius Medical Care Deutschland Gmbh | Spectroscopic detector and method for the determination of blood and biological markers in liquids |
| US8145288B2 (en) | 2006-08-22 | 2012-03-27 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
| US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
| US8190224B2 (en) | 2006-09-22 | 2012-05-29 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
| US8175671B2 (en) | 2006-09-22 | 2012-05-08 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
| US8396527B2 (en) | 2006-09-22 | 2013-03-12 | Covidien Lp | Medical sensor for reducing signal artifacts and technique for using the same |
| US7869849B2 (en) | 2006-09-26 | 2011-01-11 | Nellcor Puritan Bennett Llc | Opaque, electrically nonconductive region on a medical sensor |
| US7574245B2 (en) | 2006-09-27 | 2009-08-11 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
| US7796403B2 (en) | 2006-09-28 | 2010-09-14 | Nellcor Puritan Bennett Llc | Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit |
| US7890153B2 (en) | 2006-09-28 | 2011-02-15 | Nellcor Puritan Bennett Llc | System and method for mitigating interference in pulse oximetry |
| US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
| US7680522B2 (en) | 2006-09-29 | 2010-03-16 | Nellcor Puritan Bennett Llc | Method and apparatus for detecting misapplied sensors |
| US7476131B2 (en) | 2006-09-29 | 2009-01-13 | Nellcor Puritan Bennett Llc | Device for reducing crosstalk |
| US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
| US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
| US9308148B2 (en) | 2006-12-04 | 2016-04-12 | Thermatx, Inc. | Methods and apparatus for adjusting blood circulation |
| US8603150B2 (en) | 2006-12-04 | 2013-12-10 | Carefusion 2200, Inc. | Methods and apparatus for adjusting blood circulation |
| US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
| US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
| US7894869B2 (en) | 2007-03-09 | 2011-02-22 | Nellcor Puritan Bennett Llc | Multiple configuration medical sensor and technique for using the same |
| US9457179B2 (en) | 2007-03-20 | 2016-10-04 | Transmedics, Inc. | Systems for monitoring and applying electrical currents in an organ perfusion system |
| US8412293B2 (en) * | 2007-07-16 | 2013-04-02 | Optiscan Biomedical Corporation | Systems and methods for determining physiological parameters using measured analyte values |
| US8175668B1 (en) | 2007-10-23 | 2012-05-08 | Pacesetter, Inc. | Implantable multi-wavelength venous oxygen saturation and hematocrit sensor and method |
| US20090156916A1 (en) * | 2007-12-18 | 2009-06-18 | Huisun Wang | Catheter systems with blood measurement device and methods |
| US8352004B2 (en) | 2007-12-21 | 2013-01-08 | Covidien Lp | Medical sensor and technique for using the same |
| US8346328B2 (en) | 2007-12-21 | 2013-01-01 | Covidien Lp | Medical sensor and technique for using the same |
| US8366613B2 (en) | 2007-12-26 | 2013-02-05 | Covidien Lp | LED drive circuit for pulse oximetry and method for using same |
| US8577434B2 (en) | 2007-12-27 | 2013-11-05 | Covidien Lp | Coaxial LED light sources |
| US8442608B2 (en) | 2007-12-28 | 2013-05-14 | Covidien Lp | System and method for estimating physiological parameters by deconvolving artifacts |
| US8452364B2 (en) | 2007-12-28 | 2013-05-28 | Covidien LLP | System and method for attaching a sensor to a patient's skin |
| US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
| US8070508B2 (en) | 2007-12-31 | 2011-12-06 | Nellcor Puritan Bennett Llc | Method and apparatus for aligning and securing a cable strain relief |
| US8897850B2 (en) | 2007-12-31 | 2014-11-25 | Covidien Lp | Sensor with integrated living hinge and spring |
| US8199007B2 (en) | 2007-12-31 | 2012-06-12 | Nellcor Puritan Bennett Llc | Flex circuit snap track for a biometric sensor |
| US10750738B2 (en) | 2008-01-31 | 2020-08-25 | Transmedics, Inc. | Systems and methods for ex vivo lung care |
| US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
| US8112375B2 (en) | 2008-03-31 | 2012-02-07 | Nellcor Puritan Bennett Llc | Wavelength selection and outlier detection in reduced rank linear models |
| GB2460265A (en) * | 2008-05-23 | 2009-11-25 | Univ Dublin City | Detection assembly |
| US8071935B2 (en) | 2008-06-30 | 2011-12-06 | Nellcor Puritan Bennett Llc | Optical detector with an overmolded faraday shield |
| US7880884B2 (en) | 2008-06-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | System and method for coating and shielding electronic sensor components |
| US7887345B2 (en) | 2008-06-30 | 2011-02-15 | Nellcor Puritan Bennett Llc | Single use connector for pulse oximetry sensors |
| US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
| US8423112B2 (en) | 2008-09-30 | 2013-04-16 | Covidien Lp | Medical sensor and technique for using the same |
| US8914088B2 (en) | 2008-09-30 | 2014-12-16 | Covidien Lp | Medical sensor and technique for using the same |
| US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
| AT506798B1 (en) * | 2009-01-13 | 2009-12-15 | Smart Medical Solutions Gmbh | DEVICE FOR MEASURING AT LEAST ONE PARAMETER OF AN ARTERIAL BLOOD TEST |
| US8452366B2 (en) | 2009-03-16 | 2013-05-28 | Covidien Lp | Medical monitoring device with flexible circuitry |
| US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
| US20100249552A1 (en) * | 2009-03-31 | 2010-09-30 | Nellcor Puritan Bennett Llc | System And Method For Wirelessly Powering Medical Devices |
| KR20100109196A (en) * | 2009-03-31 | 2010-10-08 | 삼성전자주식회사 | A system and method of measuring object's concentration using for transmission or reflection of light |
| US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
| US8634891B2 (en) | 2009-05-20 | 2014-01-21 | Covidien Lp | Method and system for self regulation of sensor component contact pressure |
| ITMI20090926A1 (en) * | 2009-05-26 | 2010-11-27 | Datamed Srl | SYSTEM AND METHOD FOR SPECTROPHOTOMETRIC MEASUREMENTS OF BLOOD PARAMETERS. |
| US9010634B2 (en) | 2009-06-30 | 2015-04-21 | Covidien Lp | System and method for linking patient data to a patient and providing sensor quality assurance |
| US8505821B2 (en) | 2009-06-30 | 2013-08-13 | Covidien Lp | System and method for providing sensor quality assurance |
| US8311601B2 (en) | 2009-06-30 | 2012-11-13 | Nellcor Puritan Bennett Llc | Reflectance and/or transmissive pulse oximeter |
| US8391941B2 (en) | 2009-07-17 | 2013-03-05 | Covidien Lp | System and method for memory switching for multiple configuration medical sensor |
| US9091676B2 (en) | 2010-06-09 | 2015-07-28 | Optiscan Biomedical Corp. | Systems and methods for measuring multiple analytes in a sample |
| US8417310B2 (en) | 2009-08-10 | 2013-04-09 | Covidien Lp | Digital switching in multi-site sensor |
| US20110034783A1 (en) * | 2009-08-10 | 2011-02-10 | Nellcor Puritan Bennett Llc | Systems and methods for balancing power consumption and utility of wireless medical sensors |
| US8428675B2 (en) | 2009-08-19 | 2013-04-23 | Covidien Lp | Nanofiber adhesives used in medical devices |
| US8515511B2 (en) * | 2009-09-29 | 2013-08-20 | Covidien Lp | Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same |
| US9554739B2 (en) * | 2009-09-29 | 2017-01-31 | Covidien Lp | Smart cable for coupling a medical sensor to an electronic patient monitor |
| CN102917674A (en) | 2010-01-08 | 2013-02-06 | 康尔福盛2200公司 | Methods and apparatus for enhancing vascular access in an appendage to enhance therapeutic and interventional procedures |
| US20110201908A1 (en) * | 2010-02-17 | 2011-08-18 | Farkas Joshua D | Intermittent extracorporeal spectrophotometry |
| US9078610B2 (en) | 2010-02-22 | 2015-07-14 | Covidien Lp | Motion energy harvesting with wireless sensors |
| US8874180B2 (en) * | 2010-02-28 | 2014-10-28 | Covidien Lp | Ambient electromagnetic energy harvesting with wireless sensors |
| US8483788B2 (en) * | 2010-02-28 | 2013-07-09 | Covidien Lp | Motion compensation in a sensor |
| US8553223B2 (en) | 2010-03-31 | 2013-10-08 | Covidien Lp | Biodegradable fibers for sensing |
| US8428676B2 (en) | 2010-03-31 | 2013-04-23 | Covidien Lp | Thermoelectric energy harvesting with wireless sensors |
| US8319401B2 (en) | 2010-04-30 | 2012-11-27 | Nellcor Puritan Bennett Llc | Air movement energy harvesting with wireless sensors |
| EP2678070B1 (en) * | 2011-02-25 | 2022-10-19 | Fresenius Medical Care Holdings, Inc. | Optical blood monitoring system with a shrouded sensor clip assembly and a blood chamber |
| CN114375945A (en) | 2011-04-14 | 2022-04-22 | 特兰斯迈迪茨公司 | Organ care solution for ex vivo machine perfusion of donor lungs |
| DE102012104461A1 (en) | 2012-05-23 | 2013-12-12 | B. Braun Avitum Ag | Medical device for extracorporeal blood treatment with multiple sensor units |
| JP2015532882A (en) * | 2012-10-26 | 2015-11-16 | ノニン・メディカル・インコーポレーテッド | Self-identifying oxygen measuring sensor system |
| US20150122997A1 (en) * | 2012-11-09 | 2015-05-07 | Fenwal, Inc. | Non-Invasive Identification Of Solutions |
| CN105229448B (en) * | 2013-04-18 | 2017-11-21 | 尼普洛株式会社 | Fluid concentrations determine device |
| JP6161065B2 (en) * | 2013-07-02 | 2017-07-12 | 国立研究開発法人産業技術総合研究所 | Blood information measuring device and measuring method |
| PL227190B1 (en) * | 2013-10-10 | 2017-11-30 | Wojewódzki Szpital Specjalistyczny We Wrocławiu | Device for photobiomodulation of blood during the extracorporal circulation |
| US9308306B2 (en) | 2014-02-24 | 2016-04-12 | Fresenius Medical Care Holdings, Inc. | Self calibrating blood chamber |
| CN113287600B (en) | 2014-06-02 | 2022-08-19 | 特兰斯迈迪茨公司 | Perfusion circuit and system for perfusion of isolated liver and system for preservation thereof |
| US10653345B2 (en) | 2014-08-29 | 2020-05-19 | Fresenius Kabi Deutschland Gmbh | Blood processing apparatus comprising a holder device for a measurement device |
| WO2016132512A1 (en) * | 2015-02-19 | 2016-08-25 | 愛知時計電機株式会社 | Flow rate measurement device and tube for using therefor |
| DE102015015587A1 (en) * | 2015-08-27 | 2017-03-02 | Em-Tec Gmbh | Holding device for a hose |
| US10194655B2 (en) | 2015-09-09 | 2019-02-05 | Transmedics, Inc. | Aortic cannula for ex vivo organ care system |
| WO2017216608A1 (en) * | 2016-06-15 | 2017-12-21 | Sorin Group Italia S.R.L | Methods and devices for monitoring blood |
| WO2018005993A1 (en) * | 2016-06-30 | 2018-01-04 | Fresenius Medical Care Holdings, Inc. | Method and system for creating a diagnostic vascular window |
| JP2019213570A (en) * | 2016-10-19 | 2019-12-19 | アルプスアルパイン株式会社 | Measurement device and blood circulation apparatus |
| GB201806797D0 (en) * | 2018-04-26 | 2018-06-13 | Res Center Pharmaceutical Engineering Gmbh | Monitoring a property of a fluid during a flow process with a flow unit and a tube being movable relative to one another |
| JP7061362B2 (en) * | 2018-05-14 | 2022-04-28 | 株式会社カスタム | Non-invasive glucose meter |
| JP7102309B2 (en) * | 2018-09-25 | 2022-07-19 | 東レエンジニアリング株式会社 | Reactor unit |
| CN113749653A (en) * | 2020-06-01 | 2021-12-07 | 江苏赛腾医疗科技有限公司 | Blood oxygen monitoring equipment and blood oxygen monitoring method |
| DE202021106907U1 (en) * | 2021-12-20 | 2023-01-05 | Ferrosens Gmbh | Holding device for a light guide and/or a light guide bundle and device for the quantitative determination of at least one fluorescent, light-absorbing and/or light-reflecting component |
| WO2024015511A1 (en) * | 2022-07-13 | 2024-01-18 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods and device related to removal of cell-free plasma hemoglobin |
Family Cites Families (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2343097A1 (en) * | 1973-08-27 | 1975-03-13 | Max Planck Gesellschaft | THE PHOTOMETRIC DETERMINATION OF CONCENTRATION RATIO |
| US4114604A (en) * | 1976-10-18 | 1978-09-19 | Shaw Robert F | Catheter oximeter apparatus and method |
| US4167331A (en) * | 1976-12-20 | 1979-09-11 | Hewlett-Packard Company | Multi-wavelength incremental absorbence oximeter |
| US4303336A (en) * | 1978-08-28 | 1981-12-01 | Baxter Travenol Laboratories, Inc. | Method and apparatus for making a rapid measurement of the hematocrit of blood |
| US4209300A (en) * | 1978-09-25 | 1980-06-24 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Hemoglobin-oxygen equilibrium curve analyzer |
| US4243883A (en) * | 1979-01-19 | 1981-01-06 | Midwest Cardiovascular Institute Foundation | Blood hematocrit monitoring system |
| US4227814A (en) * | 1979-02-01 | 1980-10-14 | Baxter Travenol Laboratories, Inc. | Optical density detector |
| US4502786A (en) * | 1979-12-26 | 1985-03-05 | Helena Laboratories Corporation | Method and apparatus for automated determination of hemoglobin species |
| US4523279A (en) * | 1980-11-24 | 1985-06-11 | Oximetrix, Inc. | Apparatus for determining oxygen saturation levels in blood |
| US4447150A (en) * | 1981-02-27 | 1984-05-08 | Bentley Laboratories | Apparatus and method for measuring blood oxygen saturation |
| US4444498A (en) * | 1981-02-27 | 1984-04-24 | Bentley Laboratories | Apparatus and method for measuring blood oxygen saturation |
| US4407290A (en) * | 1981-04-01 | 1983-10-04 | Biox Technology, Inc. | Blood constituent measuring device and method |
| JPS58143243A (en) * | 1982-02-19 | 1983-08-25 | Minolta Camera Co Ltd | Measuring apparatus for coloring matter in blood without taking out blood |
| US4621643A (en) * | 1982-09-02 | 1986-11-11 | Nellcor Incorporated | Calibrated optical oximeter probe |
| US4623248A (en) * | 1983-02-16 | 1986-11-18 | Abbott Laboratories | Apparatus and method for determining oxygen saturation levels with increased accuracy |
| US4596035A (en) * | 1983-06-27 | 1986-06-17 | Ortho Diagnostic Systems Inc. | Methods for enumerating 3-part white cell differential clusters |
| US4651741A (en) * | 1985-05-30 | 1987-03-24 | Baxter Travenol Laboratories, Inc. | Method and apparatus for determining oxygen saturation in vivo |
| DK282085D0 (en) * | 1985-06-21 | 1985-06-21 | Radiometer As | METHOD AND APPARATUS FOR DETERMINING BLOOD COMPONENTS |
| US4796633A (en) * | 1985-06-25 | 1989-01-10 | American Hospital Supply Corporation | Method and apparatus for in vitro calibration of oxygen saturation monitor |
| US4936679A (en) * | 1985-11-12 | 1990-06-26 | Becton, Dickinson And Company | Optical fiber transducer driving and measuring circuit and method for using same |
| US4745279A (en) * | 1986-01-02 | 1988-05-17 | American Hospital Supply Corporation | Hematocrit measuring apparatus |
| SE459641B (en) * | 1986-03-24 | 1989-07-24 | Gambro Ab | DETECTOR SYSTEM CONTROLS A BLOOD CIRCULATION ALTERNATIVE WITH A SIGNIFICANTLY UNLESSED |
| US4759369A (en) * | 1986-07-07 | 1988-07-26 | Novametrix Medical Systems, Inc. | Pulse oximeter |
| US4869253A (en) * | 1986-08-18 | 1989-09-26 | Physio-Control Corporation | Method and apparatus for indicating perfusion and oxygen saturation trends in oximetry |
| JPS6365845A (en) * | 1986-09-05 | 1988-03-24 | ミノルタ株式会社 | Oximeter apparatus |
| US4776340A (en) * | 1987-03-23 | 1988-10-11 | Spectramed, Inc. | Hematocrit measurement by differential optical geometry in a short-term diagnostic cardiovascular catheter, and application to correction of blood-oxygen measurement |
| WO1989001144A1 (en) * | 1987-07-24 | 1989-02-09 | Terumo Kabushiki Kaisha | Apparatus for measuring concentration and oxygen saturation of hemoglobin |
| DE3726524A1 (en) * | 1987-08-10 | 1989-02-23 | Fresenius Ag | HAEMOGLOBIN DETECTOR |
| US4810090A (en) * | 1987-08-24 | 1989-03-07 | Cobe Laboratories, Inc. | Method and apparatus for monitoring blood components |
| US4805623A (en) * | 1987-09-04 | 1989-02-21 | Vander Corporation | Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment |
| US4796636A (en) * | 1987-09-10 | 1989-01-10 | Nippon Colin Co., Ltd. | Noninvasive reflectance oximeter |
| US4863265A (en) * | 1987-10-16 | 1989-09-05 | Mine Safety Appliances Company | Apparatus and method for measuring blood constituents |
| US4854699A (en) * | 1987-11-02 | 1989-08-08 | Nippon Colin Co., Ltd. | Backscatter oximeter |
| DK163194C (en) * | 1988-12-22 | 1992-06-22 | Radiometer As | METHOD OF PHOTOMETRIC IN VITRO DETERMINING A BLOOD GAS PARAMETER IN A BLOOD TEST |
| US4846183A (en) * | 1987-12-02 | 1989-07-11 | The Boc Group, Inc. | Blood parameter monitoring apparatus and methods |
| US4800885A (en) * | 1987-12-02 | 1989-01-31 | The Boc Group, Inc. | Blood constituent monitoring apparatus and methods with frequency division multiplexing |
| US4869254A (en) * | 1988-03-30 | 1989-09-26 | Nellcor Incorporated | Method and apparatus for calculating arterial oxygen saturation |
| US5361758A (en) * | 1988-06-09 | 1994-11-08 | Cme Telemetrix Inc. | Method and device for measuring concentration levels of blood constituents non-invasively |
| JPH0257239A (en) * | 1988-08-23 | 1990-02-27 | Terumo Corp | Probe for optical sensor |
| US5564417A (en) * | 1991-01-24 | 1996-10-15 | Non-Invasive Technology, Inc. | Pathlength corrected oximeter and the like |
| US5061632A (en) * | 1989-01-31 | 1991-10-29 | Board Of Regents, The University Of Texas System | Capillary tube hemoglobinometer and oximeter |
| US5048524A (en) * | 1989-03-03 | 1991-09-17 | Camino Laboratories, Inc. | Blood parameter measurement |
| US4981355A (en) * | 1989-05-12 | 1991-01-01 | Baxter International Inc. | Calibration cup for in vitro calibration of an oxygen saturation monitor and method of using same |
| ATE80225T1 (en) * | 1989-05-23 | 1992-09-15 | Biosensors Technology Inc | METHOD OF DETERMINING SUBSTANCES IN ABSORBING AND SCATTERING MATRIX MATERIALS BY RADIATION ABSORPTION. |
| DE69029152T2 (en) * | 1990-02-15 | 1997-03-06 | Hewlett Packard Gmbh | Procedure for the non-invasive measurement of oxygen saturation |
| US5115133A (en) * | 1990-04-19 | 1992-05-19 | Inomet, Inc. | Testing of body fluid constituents through measuring light reflected from tympanic membrane |
| US5066859A (en) * | 1990-05-18 | 1991-11-19 | Karkar Maurice N | Hematocrit and oxygen saturation blood analyzer |
| US5351686A (en) * | 1990-10-06 | 1994-10-04 | In-Line Diagnostics Corporation | Disposable extracorporeal conduit for blood constituent monitoring |
| US5372136A (en) * | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
| DE4204477B4 (en) * | 1991-02-15 | 2005-06-30 | Cobe Cardiovascular Inc., Arvada | Medical device, probe to be connected and control box therefor |
| US5318022A (en) * | 1991-03-01 | 1994-06-07 | John Taboada | Method and apparatus for determining hemoglobin oxygenation such as in ocular and other vascular beds |
| US5632272A (en) * | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
| US5282466A (en) * | 1991-10-03 | 1994-02-01 | Medtronic, Inc. | System for disabling oximeter in presence of ambient light |
| US5416575A (en) * | 1991-11-18 | 1995-05-16 | Schwartz; Mark | Method and system for calibrating an optical density measurement apparatus |
| US5277181A (en) * | 1991-12-12 | 1994-01-11 | Vivascan Corporation | Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis |
| US5280786A (en) * | 1992-01-21 | 1994-01-25 | Fiberoptic Sensor Technologies, Inc. | Fiberoptic blood pressure and oxygenation sensor |
| US5385143A (en) * | 1992-02-06 | 1995-01-31 | Nihon Kohden Corporation | Apparatus for measuring predetermined data of living tissue |
| US5297548A (en) * | 1992-02-07 | 1994-03-29 | Ohmeda Inc. | Arterial blood monitoring probe |
| US5331958A (en) * | 1992-03-31 | 1994-07-26 | University Of Manitoba | Spectrophotometric blood analysis |
| US5385539A (en) * | 1992-06-30 | 1995-01-31 | Advanced Haemotechnologies | Apparatus for monitoring hematocrit levels of blood |
| US5336221A (en) * | 1992-10-14 | 1994-08-09 | Premier Laser Systems, Inc. | Method and apparatus for applying thermal energy to tissue using a clamp |
| US5357954A (en) * | 1993-01-04 | 1994-10-25 | Respiratory Support Products, Inc. | Optical blood oxygen saturation probe for insertion into the esophagus |
| US5791345A (en) * | 1993-09-03 | 1998-08-11 | Toa Medical Electronics Co., Ltd. | Non-invasive blood analyzer |
| US5503148A (en) * | 1994-11-01 | 1996-04-02 | Ohmeda Inc. | System for pulse oximetry SPO2 determination |
| US5601080A (en) * | 1994-12-28 | 1997-02-11 | Coretech Medical Technologies Corporation | Spectrophotometric blood analysis |
| US5556421A (en) * | 1995-02-22 | 1996-09-17 | Intermedics, Inc. | Implantable medical device with enclosed physiological parameter sensors or telemetry link |
| US5625459A (en) * | 1995-03-03 | 1997-04-29 | Galileo Electro-Optics Corporation | Diffuse reflectance probe |
| US5774213A (en) * | 1995-04-21 | 1998-06-30 | Trebino; Rick P. | Techniques for measuring difference of an optical property at two wavelengths by modulating two sources to have opposite-phase components at a common frequency |
| JP3209044B2 (en) * | 1995-06-13 | 2001-09-17 | 住友電装株式会社 | Optical connector and method of fixing optical fiber to optical connector |
| US5673694A (en) * | 1995-08-08 | 1997-10-07 | Henry Ford Health System | Method and apparatus for continuous measurement of central venous oxygen saturation |
| US5692505A (en) * | 1996-04-25 | 1997-12-02 | Fouts; James Michael | Data processing systems and methods for pulse oximeters |
| AT404513B (en) * | 1996-07-12 | 1998-12-28 | Avl Verbrennungskraft Messtech | METHOD AND MEASURING ARRANGEMENT FOR THE OPTICAL DETERMINATION OF TOTAL HEMOGLOBIN CONCENTRATION |
| US5734464A (en) * | 1996-11-06 | 1998-03-31 | Cobe Laboratories, Inc. | Red blood cell spillover detection technique |
| US5872860A (en) * | 1997-03-13 | 1999-02-16 | Ortho Diagnostic Systems, Inc. | Calibration cassette for use in calibrating an automated agglutination reaction analyzing system |
| EP0980518B1 (en) * | 1998-02-10 | 2007-03-14 | Daedalus I, LLC | APPARATUS FOR DETERMINATION OF pH, pCO2, HEMOGLOBIN AND HEMOGLOBIN OXYGEN SATURATION |
-
1998
- 1998-11-06 US US09/186,997 patent/US6144444A/en not_active Expired - Lifetime
-
1999
- 1999-11-01 AU AU14631/00A patent/AU764970B2/en not_active Ceased
- 1999-11-01 CA CA002346074A patent/CA2346074A1/en not_active Abandoned
- 1999-11-01 EP EP99971918A patent/EP1125126A4/en not_active Withdrawn
- 1999-11-01 JP JP2000581449A patent/JP2002529174A/en active Pending
- 1999-11-01 WO PCT/US1999/025733 patent/WO2000028322A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6144444A (en) | 2000-11-07 |
| AU1463100A (en) | 2000-05-29 |
| WO2000028322A1 (en) | 2000-05-18 |
| EP1125126A4 (en) | 2004-12-29 |
| JP2002529174A (en) | 2002-09-10 |
| EP1125126A1 (en) | 2001-08-22 |
| AU764970B2 (en) | 2003-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6144444A (en) | Apparatus and method to determine blood parameters | |
| US7701581B2 (en) | Device for determining of properties in a fluid and/or constituents thereof | |
| EP0720013A2 (en) | Spectrophotometric blood analysis | |
| US6064474A (en) | Optical measurement of blood hematocrit incorporating a self-calibration algorithm | |
| US4598715A (en) | Instrument for spectral measurement in the bloodstream | |
| EP0577684B1 (en) | Method and apparatus for glucose concentration monitoring | |
| US5341805A (en) | Glucose fluorescence monitor and method | |
| US7933005B2 (en) | Modified method and apparatus for measuring analytes | |
| EP1579196B1 (en) | Method and device for measurements in blood | |
| US11241176B2 (en) | Direct light differential measurement system with increased noise immunity | |
| US5282466A (en) | System for disabling oximeter in presence of ambient light | |
| CA2610753A1 (en) | Continuous spectroscopic measurement of total hemoglobin | |
| WO2013154308A1 (en) | Device and method for measuring hemoglobin | |
| CN107529996A (en) | The non-invasive optical detecting of carbon dioxide partial pressure | |
| WO1993006774A1 (en) | Method and apparatus for determining hematocrit in blood | |
| US8523785B2 (en) | Method and apparatus for measuring analytes | |
| EP2434952B1 (en) | Apparatus and method for spectrophotometric measurements of blood parameters | |
| WO1993006775A1 (en) | Method and apparatus for determining oxygen saturation | |
| EP0484547A1 (en) | Catheter for measurement and method of measuring oxygen saturation degree or flow speed of blood | |
| KR101729379B1 (en) | Test system and method for controlling the orientation of a test strip | |
| JP7022963B2 (en) | Probe of biometric information measuring device and biometric information measuring device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |